| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.829 | 0.004 | 0.829 | Hypolipemic | 0.798 0.004 CID_6443233 0.748 0.004 CID_21917706 0.269 0.059 CID_20908 | ||
| 0.707 | 0.007 | 0.707 | Cholesterol antagonist | 0.554 0.025 CID_6443233 0.688 0.009 CID_21917706 0.295 0.094 CID_6195 0.595 0.019 CID_20908 | ||
| 0.645 | 0.004 | 0.645 | Lipid peroxidase inhibitor | 0.62 0.004 CID_6443233 0.506 0.005 CID_21917706 | ||
| 0.404 | 0.001 | 0.404 | Squalene epoxidase inhibitor | 0.217 0.002 CID_6443233 0.36 0.001 CID_21917706 0.095 0.006 CID_6195 0.069 0.014 CID_20908 | ||
| 0.35 | 0.002 | 0.35 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.057 0.008 CID_6443233 0.251 0.002 CID_21917706 0.037 0.025 CID_6195 | ||
| 0.339 | 0.028 | 0.466 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.264 0.054 CID_21917706 0.466 0.005 CID_6195 | CID_6195 | |
| 0.32 | 0.009 | 0.32 | Cyclin-dependent kinase 7 inhibitor | 0.128 0.077 CID_6443233 0.278 0.016 CID_21917706 | ||
| 0.355 | 0.083 | 0.507 | GABA C receptor rho-3 antagonist | 0.507 0.024 CID_6443233 0.218 0.186 CID_21917706 0.499 0.026 CID_6195 0.472 0.034 CID_20908 | CID_6443233 | |
| 0.378 | 0.121 | 0.639 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.395 0.105 CID_6443233 0.27 0.256 CID_21917706 0.639 0.004 CID_6195 0.475 0.046 CID_20908 | CID_6195 | |
| 0.317 | 0.071 | 0.349 | Caspase 3 stimulant | 0.311 0.073 CID_6443233 0.272 0.095 CID_21917706 0.349 0.059 CID_6195 0.261 0.103 CID_20908 | CID_6195 | |
| 0.284 | 0.052 | 0.41 | Potassium channel blocker | 0.41 0.021 CID_21917706 | CID_21917706 | |
| 0.233 | 0.013 | 0.233 | Alpha 2 adrenoreceptor antagonist | 0.112 0.04 CID_6443233 0.082 0.064 CID_21917706 | ||
| 0.263 | 0.045 | 0.263 | ErbB-1 antagonist | 0.206 0.083 CID_6443233 0.216 0.074 CID_21917706 | ||
| 0.226 | 0.011 | 0.226 | Alpha 2a adrenoreceptor antagonist | 0.139 0.025 CID_6443233 0.068 0.06 CID_21917706 | ||
| 0.208 | 0.005 | 0.208 | Adrenaline uptake inhibitor | 0.116 0.015 CID_6443233 0.112 0.016 CID_21917706 | ||
| 0.236 | 0.049 | 0.356 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.154 0.139 CID_6443233 0.223 0.056 CID_21917706 0.232 0.051 CID_6195 0.356 0.012 CID_20908 | CID_20908 | |
| 0.266 | 0.09 | 0.302 | Immunostimulant | 0.302 0.078 CID_6443233 0.283 0.084 CID_21917706 0.268 0.089 CID_6195 0.259 0.092 CID_20908 | CID_6443233 | |
| 0.216 | 0.05 | 0.251 | Growth factor agonist | 0.242 0.035 CID_6443233 0.251 0.031 CID_21917706 0.151 0.139 CID_6195 0.178 0.089 CID_20908 | CID_21917706 | |
| 0.16 | 0.003 | 0.16 | Squalene synthetase inhibitor | 0.153 0.004 CID_6443233 0.147 0.004 CID_21917706 | ||
| 0.199 | 0.065 | 0.275 | 5 Hydroxytryptamine 3E antagonist | 0.184 0.095 CID_6443233 0.275 0.008 CID_6195 0.243 0.019 CID_20908 | CID_6195 | |
| 0.145 | 0.017 | 0.145 | 5 Hydroxytryptamine uptake inhibitor | 0.056 0.049 CID_21917706 | ||
| 0.253 | 0.131 | 0.335 | Vasodilator, coronary | 0.323 0.071 CID_21917706 0.207 0.175 CID_6195 0.335 0.063 CID_20908 | CID_20908 | |
| 0.168 | 0.091 | 0.171 | MAP kinase kinase 5 inhibitor | 0.171 0.083 CID_21917706 | CID_21917706 | |
| 0.195 | 0.12 | 0.353 | DNA damaging | 0.353 0.04 CID_6195 0.343 0.043 CID_20908 | CID_6195 | |
| 0.113 | 0.039 | 0.113 | Calcium antagonist | 0.085 0.059 CID_21917706 0.076 0.067 CID_6195 0.1 0.048 CID_20908 | ||
| 0.087 | 0.015 | 0.087 | Dopamine transporter inhibitor | 0.044 0.038 CID_21917706 | ||
| 0.284 | 0.212 | 0.751 | Caspase 9 stimulant | 0.358 0.139 CID_6443233 0.266 0.233 CID_21917706 0.751 0.018 CID_6195 0.703 0.023 CID_20908 | CID_6195 | |
| 0.092 | 0.021 | 0.092 | Dopamine uptake inhibitor | 0.056 0.042 CID_21917706 | ||
| 0.128 | 0.064 | 0.202 | Papain-like protease (SARS coronavirus) inhibitor | 0.167 0.022 CID_6443233 0.111 0.107 CID_21917706 0.202 0.01 CID_6195 0.174 0.019 CID_20908 | CID_6195 | |
| 0.217 | 0.157 | 0.461 | Vasodilator, peripheral | 0.218 0.156 CID_6443233 0.223 0.151 CID_21917706 0.461 0.037 CID_20908 | CID_20908 | |
| 0.086 | 0.028 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.087 0.026 CID_6443233 0.09 0.022 CID_6195 0.088 0.024 CID_20908 | CID_6195 | |
| 0.063 | 0.009 | 0.063 | Growth hormone releasing factor agonist | 0.05 0.013 CID_6443233 0.049 0.013 CID_21917706 | ||
| 0.091 | 0.041 | 0.359 | CYP2A6 inhibitor | 0.073 0.056 CID_6443233 0.359 0.003 CID_6195 0.129 0.023 CID_20908 | CID_6195 | |
| 0.101 | 0.051 | 0.164 | Uric acid excretion stimulant | 0.12 0.038 CID_6443233 0.105 0.048 CID_21917706 0.084 0.076 CID_6195 0.164 0.019 CID_20908 | CID_20908 | |
| 0.17 | 0.121 | 0.352 | Potassium channel (Voltage-sensitive) blocker | 0.352 0.036 CID_21917706 | CID_21917706 | |
| 0.102 | 0.056 | 0.147 | Nitric-oxide synthase inhibitor | 0.147 0.024 CID_6443233 0.09 0.077 CID_20908 | CID_6443233 | |
| 0.109 | 0.065 | 0.109 | Interleukin 2 antagonist | |||
| 0.2 | 0.157 | 0.2 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.123 | 0.084 | 0.123 | Calcium channel blocker | |||
| 0.101 | 0.065 | 0.218 | Adenylate kinase inhibitor | 0.101 0.065 CID_21917706 0.157 0.024 CID_6195 0.218 0.013 CID_20908 | CID_20908 | |
| 0.056 | 0.021 | 0.058 | Adenylate cyclase 1 inhibitor | 0.055 0.022 CID_6443233 0.057 0.02 CID_6195 0.058 0.019 CID_20908 | CID_20908 | |
| 0.163 | 0.128 | 0.757 | Aldehyde oxidase inhibitor | 0.268 0.076 CID_21917706 0.757 0.005 CID_6195 0.58 0.022 CID_20908 | CID_6195 | |
| 0.048 | 0.016 | 0.05 | Diamine oxidase inhibitor | 0.035 0.029 CID_21917706 0.05 0.014 CID_20908 | CID_20908 | |
| 0.132 | 0.101 | 0.205 | GABA C receptor rho-2 antagonist | 0.192 0.033 CID_6443233 0.197 0.03 CID_6195 0.205 0.026 CID_20908 | CID_20908 | |
| 0.065 | 0.037 | 0.065 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.113 | 0.085 | 0.113 | Acetylcholinesterase inhibitor | |||
| 0.06 | 0.033 | 0.129 | Acyl-CoA dehydrogenase inhibitor | 0.052 0.04 CID_6443233 0.06 0.033 CID_21917706 0.075 0.024 CID_6195 0.129 0.011 CID_20908 | CID_20908 | |
| 0.079 | 0.053 | 0.079 | ErbB-4 antagonist | |||
| 0.093 | 0.068 | 0.189 | Sphingomyelinase inhibitor | 0.087 0.076 CID_6443233 0.099 0.061 CID_21917706 0.116 0.044 CID_6195 0.189 0.012 CID_20908 | CID_20908 | |
| 0.177 | 0.157 | 0.21 | 5 Hydroxytryptamine 1E antagonist | 0.21 0.119 CID_6195 | CID_6195 | |
| 0.058 | 0.04 | 0.058 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.105 | 0.091 | 0.105 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.029 | 0.015 | 0.082 | Calcium-sensing receptor agonist | 0.082 0.004 CID_6443233 0.026 0.019 CID_21917706 0.033 0.011 CID_20908 | CID_6443233 | |
| 0.069 | 0.061 | 0.069 | ErbB-2 antagonist | |||
| 0.022 | 0.015 | 0.023 | Vitamin D receptor antagonist | 0.023 0.014 CID_6443233 | CID_6443233 | |
| 0.121 | 0.116 | 0.179 | Thiol protease inhibitor | 0.179 0.049 CID_6443233 0.155 0.065 CID_6195 0.151 0.068 CID_20908 | CID_6443233 | |
| 0.021 | 0.017 | 0.041 | Geranylgeranyltransferase inhibitor | 0.029 0.01 CID_6443233 0.027 0.011 CID_6195 0.041 0.006 CID_20908 | CID_20908 | |
| 0.026 | 0.023 | 0.026 | Motilin receptor antagonist | |||
| 0.033 | 0.032 | 0.033 | Somatostatin 4 agonist | |||
| 0.021 | 0.019 | 0.021 | Retinoid X gamma receptor agonist | 0.021 0.019 CID_21917706 | ||
| 0.063 | 0.061 | 0.086 | Lipase inhibitor | 0.086 0.037 CID_6443233 | CID_6443233 | |
| 0.025 | 0.024 | 0.026 | Retinoid X gamma receptor antagonist | 0.026 0.021 CID_21917706 | CID_21917706 | |
| 0.037 | 0.037 | 0.058 | CF transmembrane conductance regulator antagonist | 0.058 0.005 CID_20908 | CID_20908 | |
| 0.092 | 0.092 | 0.174 | GABA C receptor antagonist | 0.137 0.038 CID_6443233 0.142 0.035 CID_6195 0.174 0.02 CID_20908 | CID_20908 | |
| 0.034 | 0.039 | 0.066 | Retinoic acid alpha receptor agonist | 0.036 0.033 CID_6443233 0.066 0.007 CID_20908 | CID_20908 | |
| 0.049 | 0.054 | 0.073 | DNA helicase inhibitor | 0.06 0.028 CID_6443233 0.054 0.038 CID_6195 0.073 0.015 CID_20908 | CID_20908 | |
| 0.154 | 0.161 | 0.355 | Antioxidant | 0.158 0.156 CID_21917706 0.355 0.045 CID_6195 0.256 0.081 CID_20908 | CID_6195 | |
| 0.024 | 0.032 | 0.06 | Liver X receptor antagonist | 0.06 0.008 CID_20908 | CID_20908 | |
| 0.076 | 0.083 | 0.106 | Estrogen-related receptor beta agonist | 0.083 0.057 CID_21917706 0.093 0.035 CID_6195 0.106 0.019 CID_20908 | CID_20908 | |
| 0.017 | 0.028 | 0.04 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.018 CID_6195 0.04 0.005 CID_20908 | CID_20908 | |
| 0.122 | 0.133 | 0.143 | Amyloid beta aggregation inhibitor | 0.143 0.113 CID_21917706 | CID_21917706 | |
| 0.118 | 0.129 | 0.201 | Arachidonic acid antagonist | 0.144 0.095 CID_21917706 0.184 0.05 CID_6195 0.201 0.032 CID_20908 | CID_20908 | |
| 0.02 | 0.032 | 0.075 | Liver X receptor beta antagonist | 0.075 0.004 CID_20908 | CID_20908 | |
| 0.118 | 0.13 | 0.208 | Adenylate cyclase stimulant | 0.153 0.058 CID_6443233 0.156 0.054 CID_6195 0.208 0.01 CID_20908 | CID_20908 | |
| 0.044 | 0.062 | 0.062 | Nicotinic receptor alpha7 subunit antagonist | 0.062 0.027 CID_20908 | CID_20908 | |
| 0.013 | 0.033 | 0.035 | Geranylgeranyltransferase I inhibitor | 0.019 0.018 CID_6443233 0.019 0.017 CID_6195 0.035 0.006 CID_20908 | CID_20908 | |
| 0.065 | 0.085 | 0.111 | Glycine receptor antagonist | 0.093 0.039 CID_6195 0.111 0.023 CID_20908 | CID_20908 | |
| 0.056 | 0.077 | 0.095 | Acetylcholine M4 receptor antagonist | 0.095 0.032 CID_6195 | CID_6195 | |
| 0.067 | 0.089 | 0.118 | Inducible nitric-oxide synthase inhibitor | 0.118 0.025 CID_6443233 0.079 0.065 CID_20908 | CID_6443233 | |
| 0.012 | 0.035 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.01 CID_6195 | CID_6195 | |
| 0.029 | 0.052 | 0.097 | GABA uptake inhibitor | 0.057 0.011 CID_6195 0.097 0.004 CID_20908 | CID_20908 | |
| 0.039 | 0.064 | 0.082 | Bruton tyrosine kinase inhibitor | 0.082 0.019 CID_20908 | CID_20908 | |
| 0.222 | 0.247 | 0.55 | Apoptosis agonist | 0.55 0.06 CID_6195 0.368 0.13 CID_20908 | CID_6195 | |
| 0.014 | 0.04 | 0.026 | Retinoic acid beta receptor agonist | 0.026 0.007 CID_20908 | CID_20908 | |
| 0.021 | 0.05 | 0.037 | Cholesterol ester transfer protein antagonist | 0.037 0.016 CID_20908 | CID_20908 | |
| 0.025 | 0.056 | 0.075 | Melatonin receptor 1A agonist | 0.038 0.015 CID_6443233 0.04 0.014 CID_6195 0.075 0.004 CID_20908 | CID_20908 | |
| 0.07 | 0.101 | 0.182 | Prolactin inhibitor | 0.117 0.04 CID_6195 0.182 0.012 CID_20908 | CID_20908 | |
| 0.14 | 0.175 | 0.262 | Spasmolytic | 0.212 0.11 CID_21917706 0.192 0.126 CID_6195 0.262 0.086 CID_20908 | CID_20908 | |
| 0.088 | 0.123 | 0.432 | Aldehyde dehydrogenase inhibitor | 0.103 0.093 CID_21917706 0.432 0.005 CID_6195 0.313 0.01 CID_20908 | CID_6195 | |
| 0.033 | 0.069 | 0.07 | Farnesyltransferase inhibitor | 0.047 0.03 CID_6195 0.07 0.015 CID_20908 | CID_20908 | |
| 0.047 | 0.084 | 0.076 | Immunoglobulin Fc receptor antagonist | 0.056 0.034 CID_6443233 0.068 0.013 CID_6195 0.076 0.008 CID_20908 | CID_20908 | |
| 0.057 | 0.094 | 0.085 | Acetylcholine nicotinic antagonist | 0.075 0.06 CID_6195 0.085 0.05 CID_20908 | CID_20908 | |
| 0.112 | 0.151 | 0.208 | Nitric oxide antagonist | 0.208 0.065 CID_6195 0.162 0.086 CID_20908 | CID_6195 | |
| 0.026 | 0.065 | 0.047 | Delayed rectifier potassium channel blocker | 0.047 0.014 CID_20908 | CID_20908 | |
| 0.054 | 0.094 | 0.071 | Calcium channel P-type blocker | 0.061 0.053 CID_6195 0.071 0.027 CID_20908 | CID_20908 | |
| 0.021 | 0.063 | 0.038 | Melanocortin 1 antagonist | 0.038 0.027 CID_6443233 | CID_6443233 | |
| 0.02 | 0.062 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.009 CID_20908 | CID_20908 | |
| 0.035 | 0.079 | 0.049 | Benzodiazepine antagonist | 0.049 0.028 CID_6195 | CID_6195 | |
| 0.014 | 0.059 | 0.027 | Follicle-stimulating hormone antagonist | 0.027 0.005 CID_6195 0.024 0.007 CID_20908 | CID_6195 | |
| 0.183 | 0.229 | 0.258 | Ca(v)3.3 blocker | 0.258 0.089 CID_6443233 | CID_6443233 | |
| 0.072 | 0.12 | 0.157 | GABA C receptor rho-1 antagonist | 0.121 0.039 CID_6443233 0.136 0.028 CID_6195 0.157 0.019 CID_20908 | CID_20908 | |
| 0.006 | 0.055 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 CID_6195 0.014 0.007 CID_20908 | CID_6195 | |
| 0.069 | 0.118 | 0.292 | GABA C receptor agonist | 0.109 0.058 CID_6443233 0.227 0.016 CID_6195 0.292 0.01 CID_20908 | CID_20908 | |
| 0.036 | 0.085 | 0.075 | Leukotriene B4 antagonist | 0.075 0.017 CID_20908 | CID_20908 | |
| 0.028 | 0.078 | 0.058 | Nerve growth factor antagonist | 0.058 0.01 CID_6195 0.053 0.015 CID_20908 | CID_6195 | |
| 0.012 | 0.065 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.014 CID_20908 | CID_20908 | |
| 0.017 | 0.071 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.018 CID_20908 | CID_20908 | |
| 0.035 | 0.089 | 0.066 | CXC chemokine 4 receptor antagonist | 0.066 0.038 CID_6443233 | CID_6443233 | |
| 0.02 | 0.074 | 0.032 | Hedgehog signaling activator | 0.027 0.02 CID_6195 0.032 0.009 CID_20908 | CID_20908 | |
| 0.037 | 0.092 | 0.054 | Acetylcholine M5 receptor antagonist | 0.054 0.051 CID_20908 | CID_20908 | |
| 0.075 | 0.131 | 0.113 | Phosphodiesterase 6D inhibitor | 0.113 0.032 CID_20908 | CID_20908 | |
| 0.019 | 0.076 | 0.035 | HMG CoA reductase inhibitor | 0.035 0.023 CID_20908 | CID_20908 | |
| 0.118 | 0.177 | 0.181 | ATPase inhibitor | 0.148 0.104 CID_6195 0.181 0.056 CID_20908 | CID_20908 | |
| 0.076 | 0.136 | 0.102 | Cholinergic antagonist | 0.102 0.093 CID_20908 | CID_20908 | |
| 0.017 | 0.077 | 0.073 | Retinoid X alpha receptor agonist | 0.034 0.025 CID_6195 0.073 0.009 CID_20908 | CID_20908 | |
| 0.073 | 0.134 | 0.161 | Alkylator | 0.116 0.072 CID_6195 0.161 0.041 CID_20908 | CID_20908 | |
| 0.012 | 0.075 | 0.024 | Retinoid X beta receptor antagonist | 0.021 0.014 CID_6195 0.024 0.008 CID_20908 | CID_20908 | |
| 0.024 | 0.087 | 0.057 | Potassium channel Kv1.3 blocker | 0.057 0.023 CID_6195 0.051 0.028 CID_20908 | CID_6195 | |
| 0.042 | 0.106 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.098 0.034 CID_6195 0.106 0.027 CID_20908 | CID_20908 | |
| 0.049 | 0.114 | 0.152 | MAO B inhibitor | 0.152 0.036 CID_6195 0.111 0.055 CID_20908 | CID_6195 | |
| 0.068 | 0.133 | 0.186 | MAO inhibitor | 0.186 0.045 CID_6195 0.137 0.066 CID_20908 | CID_6195 | |
| 0.034 | 0.1 | 0.071 | Potassium channel Kv1.5 blocker | 0.071 0.029 CID_6443233 | CID_6443233 | |
| 0.053 | 0.12 | 0.084 | MAO A inhibitor | 0.084 0.076 CID_6195 0.082 0.079 CID_20908 | CID_6195 | |
| 0.048 | 0.12 | 0.131 | Ornithine decarboxylase inhibitor | 0.124 0.023 CID_6195 0.131 0.019 CID_20908 | CID_20908 | |
| 0.095 | 0.169 | 0.153 | Vanilloid 1 agonist | 0.136 0.056 CID_6443233 0.112 0.108 CID_6195 0.153 0.035 CID_20908 | CID_20908 | |
| 0.071 | 0.146 | 0.1 | Acetylcholine antagonist | 0.1 0.093 CID_20908 | CID_20908 | |
| 0.158 | 0.233 | 0.348 | Tyrosine 3 hydroxylase inhibitor | 0.193 0.148 CID_6443233 0.31 0.029 CID_6195 0.348 0.016 CID_20908 | CID_20908 | |
| 0.035 | 0.113 | 0.08 | Nicotinic alpha3beta2 receptor antagonist | 0.06 0.026 CID_6195 0.08 0.013 CID_20908 | CID_20908 | |
| 0.012 | 0.09 | 0.066 | Retinoid X receptor agonist | 0.032 0.027 CID_6195 0.066 0.012 CID_20908 | CID_20908 | |
| 0.011 | 0.09 | 0.023 | Retinoic acid receptor agonist | 0.023 0.017 CID_20908 | CID_20908 | |
| 0.007 | 0.088 | 0.029 | Follicle-stimulating hormone agonist | 0.029 0.01 CID_6195 | CID_6195 | |
| 0.118 | 0.201 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.165 0.018 CID_6195 0.18 0.007 CID_20908 | CID_20908 | |
| 0.024 | 0.109 | 0.04 | Plasmepsin II inhibitor | 0.04 0.03 CID_20908 | CID_20908 | |
| 0.061 | 0.146 | 0.14 | Anesthetic local | 0.14 0.054 CID_20908 | CID_20908 | |
| 0.003 | 0.09 | 0.018 | Lysophosphatidic acid receptor 3 agonist | 0.018 0.006 CID_20908 | CID_20908 | |
| 0.061 | 0.15 | 0.144 | Anabolic | 0.144 0.021 CID_6195 0.138 0.025 CID_20908 | CID_6195 | |
| 0.012 | 0.103 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.02 CID_6195 0.032 0.01 CID_20908 | CID_20908 | |
| 0.011 | 0.102 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.01 CID_20908 | CID_20908 | |
| 0.009 | 0.101 | 0.029 | Leukotriene B4 receptor 2 antagonist | 0.029 0.009 CID_20908 | CID_20908 | |
| 0.037 | 0.129 | 0.144 | Elastase 1 inhibitor | 0.144 0.007 CID_6195 0.081 0.034 CID_20908 | CID_6195 | |
| 0.019 | 0.112 | 0.042 | Retinoid X alpha receptor antagonist | 0.032 0.028 CID_6195 0.042 0.013 CID_20908 | CID_20908 | |
| 0.013 | 0.109 | 0.031 | Vanilloid 2 agonist | 0.031 0.009 CID_20908 | CID_20908 | |
| 0.158 | 0.256 | 0.324 | Apoptosis antagonist | 0.311 0.078 CID_6195 0.324 0.07 CID_20908 | CID_20908 | |
| 0.045 | 0.144 | 0.102 | Histamine N-methyltransferase inhibitor | 0.096 0.049 CID_6195 0.102 0.044 CID_20908 | CID_20908 | |
| 0.021 | 0.12 | 0.048 | Retinoid X receptor antagonist | 0.036 0.03 CID_6195 0.048 0.014 CID_20908 | CID_20908 | |
| 0.107 | 0.207 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.115 CID_20908 | CID_20908 | |
| 0.016 | 0.115 | 0.043 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.014 CID_20908 | CID_20908 | |
| 0.023 | 0.123 | 0.053 | Cannabinoid CB1 receptor agonist | 0.053 0.05 CID_20908 | CID_20908 | |
| 0.052 | 0.152 | 0.293 | HIV-1 integrase (Overall Integration) inhibitor | 0.167 0.02 CID_6195 0.293 0.004 CID_20908 | CID_20908 | |
| 0.005 | 0.106 | 0.011 | Melatonin 2 antagonist | 0.011 0.01 CID_20908 | CID_20908 | |
| 0.06 | 0.162 | 0.191 | Adenylate cyclase inhibitor | 0.155 0.042 CID_6195 0.191 0.027 CID_20908 | CID_20908 | |
| 0.017 | 0.123 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.034 0.008 CID_20908 | CID_20908 | |
| 0.029 | 0.138 | 0.077 | Neuronal nicotinic receptor antagonist | 0.077 0.039 CID_20908 | CID_20908 | |
| 0.037 | 0.149 | 0.093 | Phospholipase D inhibitor | 0.086 0.026 CID_6195 0.093 0.02 CID_20908 | CID_20908 | |
| 0.054 | 0.166 | 0.274 | Ferrochelatase inhibitor | 0.241 0.014 CID_6195 0.274 0.01 CID_20908 | CID_20908 | |
| 0.022 | 0.136 | 0.056 | Thymidine kinase inhibitor | 0.056 0.015 CID_20908 | CID_20908 | |
| 0.057 | 0.172 | 0.151 | Lanosterol 14 alpha demethylase inhibitor | 0.116 0.035 CID_6195 0.151 0.011 CID_20908 | CID_20908 | |
| 0.015 | 0.131 | 0.064 | Angiotensin II receptor antagonist | 0.051 0.006 CID_6195 0.064 0.004 CID_20908 | CID_20908 | |
| 0.058 | 0.173 | 0.087 | ABCA1 expression enhancer | 0.087 0.072 CID_20908 | CID_20908 | |
| 0.079 | 0.195 | 0.204 | Neurotrophic factor | 0.204 0.026 CID_6195 | CID_6195 | |
| 0.019 | 0.137 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.015 CID_6195 0.044 0.01 CID_20908 | CID_20908 | |
| 0.017 | 0.138 | 0.075 | Thymidylate synthase inhibitor | 0.042 0.038 CID_6195 0.075 0.009 CID_20908 | CID_20908 | |
| 0.084 | 0.208 | 0.144 | Cyclin-dependent kinase 8 inhibitor | 0.144 0.085 CID_20908 | CID_20908 | |
| 0.137 | 0.262 | 0.203 | Neuropeptide Y2 antagonist | 0.189 0.14 CID_6195 0.203 0.114 CID_20908 | CID_20908 | |
| 0.049 | 0.175 | 0.158 | Estrogen receptor alpha antagonist | 0.158 0.011 CID_6195 0.104 0.025 CID_20908 | CID_6195 | |
| 0.032 | 0.158 | 0.081 | Factor III inhibitor | 0.047 0.042 CID_6195 0.081 0.007 CID_20908 | CID_20908 | |
| 0.075 | 0.2 | 0.127 | Acetylcholine M1 receptor antagonist | 0.127 0.1 CID_20908 | CID_20908 | |
| 0.022 | 0.148 | 0.046 | Histamine H1 receptor agonist | 0.046 0.026 CID_6195 | CID_6195 | |
| 0.01 | 0.137 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.007 CID_20908 | CID_20908 | |
| 0.012 | 0.14 | 0.092 | Estradiol 17 beta-dehydrogenase inhibitor | 0.092 0.011 CID_6195 0.071 0.015 CID_20908 | CID_6195 | |
| 0.129 | 0.257 | 0.283 | Gastrin inhibitor | 0.222 0.116 CID_6195 0.283 0.046 CID_20908 | CID_20908 | |
| 0.035 | 0.164 | 0.104 | Protease 3C (Human rhinovirus) inhibitor | 0.104 0.014 CID_6195 0.078 0.029 CID_20908 | CID_6195 | |
| 0.034 | 0.164 | 0.104 | Pregnane X receptor antagonist | 0.104 0.003 CID_6195 0.064 0.022 CID_20908 | CID_6195 | |
| 0.114 | 0.244 | 0.158 | Heat shock protein 70 antagonist | 0.142 0.067 CID_6195 0.158 0.031 CID_20908 | CID_20908 | |
| 0.152 | 0.284 | 0.413 | 5 Hydroxytryptamine uptake stimulant | 0.333 0.031 CID_6195 0.413 0.012 CID_20908 | CID_20908 | |
| 0.12 | 0.252 | 0.541 | 5 Hydroxytryptamine release stimulant | 0.328 0.062 CID_6195 0.541 0.021 CID_20908 | CID_20908 | |
| 0.031 | 0.164 | 0.094 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.048 CID_6195 0.094 0.01 CID_20908 | CID_20908 | |
| 0.073 | 0.206 | 0.276 | Protein kinase stimulant | 0.203 0.04 CID_6195 0.276 0.02 CID_20908 | CID_20908 | |
| 0.022 | 0.155 | 0.087 | 5 Hydroxytryptamine 1D antagonist | 0.087 0.028 CID_6195 | CID_6195 | |
| 0.067 | 0.2 | 0.166 | Nav1.2 sodium channel blocker | 0.166 0.049 CID_20908 | CID_20908 | |
| 0.047 | 0.182 | 0.096 | Gastric antisecretory | 0.096 0.071 CID_20908 | CID_20908 | |
| 0.017 | 0.151 | 0.039 | Membrane dipeptidase inhibitor | 0.039 0.028 CID_20908 | CID_20908 | |
| 0.013 | 0.148 | 0.058 | Geranyltranstransferase inhibitor | 0.058 0.015 CID_20908 | CID_20908 | |
| 0.155 | 0.291 | 0.33 | Antibacterial | 0.33 0.114 CID_6195 0.31 0.128 CID_20908 | CID_6195 | |
| 0.06 | 0.197 | 0.637 | Alpha-N-acetylglucosaminidase inhibitor | 0.411 0.008 CID_6195 0.637 0.004 CID_20908 | CID_20908 | |
| 0.009 | 0.146 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 CID_20908 | CID_20908 | |
| 0.006 | 0.147 | 0.048 | Progesterone antagonist | 0.048 0.019 CID_6195 0.031 0.028 CID_20908 | CID_6195 | |
| 0.009 | 0.15 | 0.056 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.056 0.009 CID_6195 0.052 0.01 CID_20908 | CID_6195 | |
| 0.014 | 0.155 | 0.05 | Oleamide hydrolase inhibitor | 0.05 0.028 CID_6195 | CID_6195 | |
| 0.003 | 0.145 | 0.02 | Adenosine A2a receptor agonist | 0.02 0.008 CID_20908 | CID_20908 | |
| 0.006 | 0.148 | 0.028 | Methionyl aminopeptidase 2 inhibitor | 0.024 0.019 CID_6195 0.028 0.015 CID_20908 | CID_20908 | |
| 0.065 | 0.208 | 0.158 | Cathepsin H inhibitor | 0.15 0.046 CID_6195 0.158 0.041 CID_20908 | CID_20908 | |
| 0.009 | 0.153 | 0.063 | Phosphoglycerate kinase inhibitor | 0.063 0.011 CID_20908 | CID_20908 | |
| 0.036 | 0.181 | 0.162 | GABA aminotransferase inhibitor | 0.162 0.006 CID_6195 0.103 0.025 CID_20908 | CID_6195 | |
| 0.082 | 0.23 | 0.223 | HERG channel blocker | 0.223 0.078 CID_21917706 | CID_21917706 | |
| 0.09 | 0.239 | 0.172 | Antiamyloidogenic | 0.172 0.121 CID_6195 0.169 0.124 CID_20908 | CID_6195 | |
| 0.047 | 0.195 | 0.105 | Vanilloid 4 agonist | 0.079 0.043 CID_6195 0.105 0.013 CID_20908 | CID_20908 | |
| 0.097 | 0.247 | 0.385 | Neurotrophic factor enhancer | 0.338 0.011 CID_6195 0.385 0.006 CID_20908 | CID_20908 | |
| 0.023 | 0.173 | 0.089 | Leukotriene antagonist | 0.089 0.027 CID_20908 | CID_20908 | |
| 0.047 | 0.2 | 0.145 | Cholesterol synthesis inhibitor | 0.102 0.085 CID_6195 0.145 0.047 CID_20908 | CID_20908 | |
| 0.028 | 0.182 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 CID_6195 | CID_6195 | |
| 0.011 | 0.165 | 0.029 | Purinergic P2Y15 antagonist | 0.028 0.021 CID_6195 0.029 0.018 CID_20908 | CID_20908 | |
| 0.007 | 0.161 | 0.032 | Imidazoline I1 receptor antagonist | 0.025 0.009 CID_6195 0.032 0.006 CID_20908 | CID_20908 | |
| 0.063 | 0.217 | 0.225 | TRPA1 agonist | 0.225 0.007 CID_6195 0.122 0.056 CID_20908 | CID_6195 | |
| 0.005 | 0.162 | 0.021 | Telomerase stimulant | 0.021 0.006 CID_20908 | CID_20908 | |
| 0.021 | 0.178 | 0.055 | Cholesterol esterase inhibitor | 0.055 0.023 CID_6195 0.05 0.03 CID_20908 | CID_6195 | |
| 0.062 | 0.219 | 0.116 | CDC-like kinase 3 inhibitor | 0.116 0.048 CID_6195 | CID_6195 | |
| 0.001 | 0.159 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 CID_6195 | CID_6195 | |
| 0.02 | 0.179 | 0.072 | 5 Hydroxytryptamine 1B antagonist | 0.072 0.039 CID_6195 | CID_6195 | |
| 0.009 | 0.169 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 CID_20908 | CID_20908 | |
| 0.036 | 0.196 | 0.114 | Somatostatin 1 agonist | 0.114 0.026 CID_20908 | CID_20908 | |
| 0.006 | 0.167 | 0.059 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.059 0.005 CID_6195 0.025 0.014 CID_20908 | CID_6195 | |
| 0.018 | 0.181 | 0.073 | Prolyl endopeptidase inhibitor | 0.073 0.014 CID_6195 0.048 0.039 CID_20908 | CID_6195 | |
| 0.01 | 0.176 | 0.052 | Ribonucleoside-diphosphate reductase inhibitor | 0.052 0.039 CID_20908 | CID_20908 | |
| 0.03 | 0.199 | 0.1 | Potassium channel intermediate-conductance Ca-activated blocker | 0.08 0.017 CID_6195 0.1 0.009 CID_20908 | CID_20908 | |
| 0.007 | 0.177 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_20908 | CID_20908 | |
| 0.012 | 0.183 | 0.059 | Dopamine D5 agonist | 0.052 0.016 CID_6195 0.059 0.012 CID_20908 | CID_20908 | |
| 0.018 | 0.189 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.038 CID_6195 0.071 0.014 CID_20908 | CID_20908 | |
| 0.009 | 0.182 | 0.053 | Ribonucleotide reductase inhibitor | 0.053 0.04 CID_20908 | CID_20908 | |
| 0.01 | 0.183 | 0.05 | Melatonin 2 agonist | 0.05 0.01 CID_6195 0.04 0.016 CID_20908 | CID_6195 | |
| 0.011 | 0.184 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.059 0.011 CID_6195 0.046 0.02 CID_20908 | CID_6195 | |
| 0.021 | 0.195 | 0.047 | Vanilloid 3 antagonist | 0.039 0.024 CID_6195 0.047 0.012 CID_20908 | CID_20908 | |
| 0.058 | 0.233 | 0.248 | Photosensitizer | 0.142 0.036 CID_6195 0.248 0.006 CID_20908 | CID_20908 | |
| 0.048 | 0.223 | 0.101 | DNA polymerase I inhibitor | 0.101 0.085 CID_20908 | CID_20908 | |
| 0.004 | 0.179 | 0.038 | Arginase inhibitor | 0.038 0.024 CID_20908 | CID_20908 | |
| 0.054 | 0.23 | 0.332 | Carbonic anhydrase XV inhibitor | 0.129 0.041 CID_6195 0.332 0.006 CID_20908 | CID_20908 | |
| 0.003 | 0.18 | 0.03 | Human herpes virus 5 capsid protein P40 inhibitor | 0.03 0.004 CID_20908 | CID_20908 | |
| 0.028 | 0.205 | 0.071 | NMDA receptor agonist | 0.071 0.035 CID_20908 | CID_20908 | |
| 0.021 | 0.198 | 0.132 | Aconitate hydratase inhibitor | 0.098 0.009 CID_6195 0.132 0.005 CID_20908 | CID_20908 | |
| 0.058 | 0.236 | 0.25 | Toll-Like receptor 2 antagonist | 0.25 0.009 CID_6195 0.228 0.014 CID_20908 | CID_6195 | |
| 0.074 | 0.253 | 0.231 | Insulin sensitizer | 0.212 0.061 CID_6195 0.231 0.046 CID_20908 | CID_20908 | |
| 0.008 | 0.188 | 0.062 | Fumarate hydratase inhibitor | 0.036 0.022 CID_6195 0.062 0.01 CID_20908 | CID_20908 | |
| 0.037 | 0.217 | 0.088 | Exportin-1 inhibitor | 0.088 0.016 CID_6195 0.08 0.025 CID_20908 | CID_6195 | |
| 0.005 | 0.185 | 0.036 | Leukotriene B4 receptor 1 antagonist | 0.036 0.014 CID_20908 | CID_20908 | |
| 0.101 | 0.282 | 0.174 | Neurotensin receptor agonist | 0.152 0.096 CID_6195 0.174 0.056 CID_20908 | CID_20908 | |
| 0.019 | 0.2 | 0.059 | Alpha 2 adrenoreceptor agonist | 0.054 0.051 CID_6195 0.059 0.044 CID_20908 | CID_20908 | |
| 0.014 | 0.196 | 0.073 | Ceramide glucosyltransferase inhibitor | 0.073 0.003 CID_20908 | CID_20908 | |
| 0.021 | 0.204 | 0.051 | Kainate receptor agonist | 0.044 0.023 CID_6195 0.051 0.013 CID_20908 | CID_20908 | |
| 0.022 | 0.206 | 0.058 | Dopamine beta hydroxylase inhibitor | 0.049 0.034 CID_6195 0.058 0.017 CID_20908 | CID_20908 | |
| 0.006 | 0.19 | 0.068 | Glucagon receptor antagonist | 0.068 0.006 CID_20908 | CID_20908 | |
| 0.027 | 0.212 | 0.195 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.191 0.01 CID_6195 0.195 0.01 CID_20908 | CID_20908 | |
| 0.004 | 0.189 | 0.028 | Alpha 2c adrenoreceptor agonist | 0.028 0.005 CID_6195 0.018 0.013 CID_20908 | CID_6195 | |
| 0.007 | 0.192 | 0.031 | AMPA 3 receptor antagonist | 0.031 0.02 CID_6195 | CID_6195 | |
| 0.02 | 0.205 | 0.071 | CC chemokine 4 receptor antagonist | 0.071 0.009 CID_20908 | CID_20908 | |
| 0.004 | 0.19 | 0.042 | Prostaglandin EP2 agonist | 0.042 0.008 CID_20908 | CID_20908 | |
| 0.016 | 0.203 | 0.189 | Alcohol oxidase inhibitor | 0.153 0.01 CID_6195 0.189 0.007 CID_20908 | CID_20908 | |
| 0.007 | 0.195 | 0.05 | TRPM8 blocker | 0.044 0.02 CID_6195 0.05 0.016 CID_20908 | CID_20908 | |
| 0.027 | 0.215 | 0.113 | Aminopeptidase I inhibitor | 0.09 0.034 CID_6195 0.113 0.022 CID_20908 | CID_20908 | |
| 0.021 | 0.211 | 0.104 | Glucose-6-phosphate isomerase inhibitor | 0.072 0.012 CID_6195 0.104 0.004 CID_20908 | CID_20908 | |
| 0.01 | 0.202 | 0.032 | Lysophosphatidic acid 2 receptor antagonist | 0.032 0.019 CID_20908 | CID_20908 | |
| 0.021 | 0.213 | 0.09 | Androgen agonist | 0.09 0.019 CID_20908 | CID_20908 | |
| 0.01 | 0.202 | 0.027 | Acid ceramidase inhibitor | 0.027 0.015 CID_20908 | CID_20908 | |
| 0.014 | 0.207 | 0.082 | Sphingosine 1-phosphate receptor agonist | 0.082 0.008 CID_20908 | CID_20908 | |
| 0.036 | 0.23 | 0.065 | Histone deacetylase SIRT3 inhibitor | 0.065 0.036 CID_20908 | CID_20908 | |
| 0.087 | 0.281 | 0.283 | Succinate dehydrogenase inhibitor | 0.259 0.019 CID_6195 0.283 0.014 CID_20908 | CID_20908 | |
| 0.003 | 0.197 | 0.027 | Prostaglandin H2 antagonist | 0.027 0.016 CID_20908 | CID_20908 | |
| 0.033 | 0.229 | 0.19 | Glutamate dehydrogenase inhibitor | 0.19 0.011 CID_6195 0.144 0.017 CID_20908 | CID_6195 | |
| 0.015 | 0.212 | 0.064 | Fibroblast growth factor 4 antagonist | 0.064 0.033 CID_6195 | CID_6195 | |
| 0.007 | 0.204 | 0.034 | Peroxisome proliferator-activated receptor delta agonist | 0.034 0.022 CID_20908 | CID_20908 | |
| 0.007 | 0.205 | 0.06 | Prostaglandin EP4 antagonist | 0.06 0.007 CID_20908 | CID_20908 | |
| 0.007 | 0.204 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.041 0.011 CID_6195 | CID_6195 | |
| 0.019 | 0.218 | 0.08 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.08 0.024 CID_20908 | CID_20908 | |
| 0.015 | 0.214 | 0.077 | Liver X receptor alpha agonist | 0.077 0.007 CID_20908 | CID_20908 | |
| 0.004 | 0.204 | 0.019 | Adenosine A2 receptor agonist | 0.019 0.008 CID_20908 | CID_20908 | |
| 0.007 | 0.209 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.025 0.022 CID_6195 0.034 0.009 CID_20908 | CID_20908 | |
| 0.006 | 0.208 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 CID_6195 0.015 0.012 CID_20908 | CID_6195 | |
| 0.039 | 0.243 | 0.353 | UDP-glucose 4-epimerase inhibitor | 0.202 0.018 CID_6195 0.353 0.008 CID_20908 | CID_20908 | |
| 0.002 | 0.207 | 0.012 | Imidazoline I2 receptor antagonist | 0.012 0.006 CID_20908 | CID_20908 | |
| 0.008 | 0.213 | 0.059 | Liver X receptor beta agonist | 0.059 0.008 CID_20908 | CID_20908 | |
| 0.035 | 0.241 | 0.097 | Glycine receptor agonist | 0.08 0.038 CID_6195 0.097 0.023 CID_20908 | CID_20908 | |
| 0.017 | 0.224 | 0.089 | Alpha-mannosidase inhibitor | 0.052 0.039 CID_6195 0.089 0.008 CID_20908 | CID_20908 | |
| 0.01 | 0.218 | 0.065 | Angiotensin AT1 receptor antagonist | 0.06 0.006 CID_6195 0.065 0.004 CID_20908 | CID_20908 | |
| 0.002 | 0.21 | 0.021 | Peroxisome proliferator-activated receptor alpha antagonist | 0.021 0.015 CID_6195 | CID_6195 | |
| 0.007 | 0.215 | 0.059 | Antimetabolite | 0.059 0.026 CID_20908 | CID_20908 | |
| 0.033 | 0.242 | 0.116 | Falcipain 3 inhibitor | 0.109 0.062 CID_6195 0.116 0.057 CID_20908 | CID_20908 | |
| 0.056 | 0.265 | 0.123 | Acetylcholine release stimulant | 0.106 0.074 CID_6195 0.123 0.044 CID_20908 | CID_20908 | |
| 0.023 | 0.233 | 0.087 | Botulinum neurotoxin type A inhibitor | 0.087 0.014 CID_6195 | CID_6195 | |
| 0.034 | 0.245 | 0.079 | Beta 2 adrenoreceptor agonist | 0.079 0.01 CID_20908 | CID_20908 | |
| 0.022 | 0.233 | 0.127 | Glutamate decarboxylase inhibitor | 0.113 0.023 CID_6195 0.127 0.019 CID_20908 | CID_20908 | |
| 0.048 | 0.26 | 0.251 | Psychostimulant | 0.235 0.064 CID_6195 0.251 0.058 CID_20908 | CID_20908 | |
| 0.016 | 0.229 | 0.206 | Phosphofructokinase-1 inhibitor | 0.206 0.01 CID_6195 0.196 0.011 CID_20908 | CID_6195 | |
| 0.004 | 0.218 | 0.043 | Free fatty acid receptor 1 agonist | 0.043 0.005 CID_20908 | CID_20908 | |
| 0.002 | 0.216 | 0.011 | Thromboxane agonist | 0.011 0.007 CID_20908 | CID_20908 | |
| 0.004 | 0.219 | 0.02 | Retinoic acid alpha receptor antagonist | 0.02 0.014 CID_20908 | CID_20908 | |
| 0.007 | 0.222 | 0.064 | Sphingosine 1-phosphate receptor 1 agonist | 0.064 0.011 CID_20908 | CID_20908 | |
| 0.018 | 0.234 | 0.176 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.09 0.017 CID_6195 0.176 0.007 CID_20908 | CID_20908 | |
| 0.054 | 0.27 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.043 CID_6195 0.087 0.044 CID_20908 | CID_20908 | |
| 0.002 | 0.218 | 0.024 | Angiotensin AT1B receptor antagonist | 0.015 0.009 CID_6195 0.024 0.005 CID_20908 | CID_20908 | |
| 0.019 | 0.236 | 0.151 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.151 0.005 CID_6195 0.106 0.009 CID_20908 | CID_6195 | |
| 0.035 | 0.252 | 0.07 | Phosphodiesterase VI inhibitor | 0.07 0.063 CID_20908 | CID_20908 | |
| 0.004 | 0.222 | 0.022 | Adenosine kinase inhibitor | 0.022 0.014 CID_20908 | CID_20908 | |
| 0.003 | 0.222 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.028 0.019 CID_6195 0.042 0.011 CID_20908 | CID_20908 | |
| 0.02 | 0.239 | 0.474 | Porphobilinogen synthase inhibitor | 0.474 0.004 CID_6195 0.44 0.004 CID_20908 | CID_6195 | |
| 0.02 | 0.24 | 0.057 | Thromboxane synthase inhibitor | 0.057 0.032 CID_20908 | CID_20908 | |
| 0.042 | 0.262 | 0.195 | Nav1.6 sodium channel blocker | 0.123 0.091 CID_6195 0.195 0.021 CID_20908 | CID_20908 | |
| 0.004 | 0.224 | 0.04 | Alpha 2a adrenoreceptor agonist | 0.04 0.004 CID_6195 | CID_6195 | |
| 0.003 | 0.224 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 CID_20908 | CID_20908 | |
| 0.012 | 0.236 | 0.046 | Complement factor 1s inhibitor | 0.046 0.003 CID_6195 0.04 0.004 CID_20908 | CID_6195 | |
| 0.025 | 0.249 | 0.13 | Cathepsin G inhibitor | 0.066 0.059 CID_6195 0.13 0.025 CID_20908 | CID_20908 | |
| 0.034 | 0.258 | 0.107 | Sphingosine 1-phosphate receptor antagonist | 0.107 0.018 CID_20908 | CID_20908 | |
| 0.164 | 0.389 | 0.494 | Antiinflammatory | 0.485 0.094 CID_21917706 0.494 0.09 CID_20908 | CID_20908 | |
| 0.063 | 0.289 | 0.18 | Transcription factor STAT6 inhibitor | 0.18 0.01 CID_6195 0.121 0.059 CID_20908 | CID_6195 | |
| 0.009 | 0.237 | 0.042 | ATP citrate lysase inhibitor | 0.042 0.011 CID_20908 | CID_20908 | |
| 0.042 | 0.27 | 0.244 | NADH dehydrogenase inhibitor | 0.125 0.026 CID_6195 0.244 0.008 CID_20908 | CID_20908 | |
| 0.019 | 0.247 | 0.188 | Phenylalanine 4-hydroxylase inhibitor | 0.116 0.019 CID_6195 0.188 0.008 CID_20908 | CID_20908 | |
| 0.011 | 0.242 | 0.031 | Melatonin 1 agonist | 0.031 0.027 CID_20908 | CID_20908 | |
| 0.019 | 0.25 | 0.09 | Cytokine production stimulant | 0.09 0.004 CID_20908 | CID_20908 | |
| 0.016 | 0.25 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.024 CID_6195 | CID_6195 | |
| 0.024 | 0.259 | 0.078 | Metalloproteinase-2 inhibitor | 0.078 0.054 CID_20908 | CID_20908 | |
| 0.011 | 0.246 | 0.053 | RNA-directed RNA polymerase inhibitor | 0.053 0.012 CID_20908 | CID_20908 | |
| 0.008 | 0.243 | 0.076 | Guanylate cyclase inhibitor | 0.045 0.026 CID_6195 0.076 0.004 CID_20908 | CID_20908 | |
| 0.002 | 0.237 | 0.014 | Prostaglandin EP4 agonist | 0.014 0.011 CID_20908 | CID_20908 | |
| 0.006 | 0.245 | 0.026 | Alpha 2b adrenoreceptor agonist | 0.026 0.005 CID_6195 0.022 0.008 CID_20908 | CID_6195 | |
| 0.07 | 0.31 | 0.245 | Melanin inhibitor | 0.245 0.029 CID_6195 0.207 0.038 CID_20908 | CID_6195 | |
| 0.014 | 0.255 | 0.105 | Prostaglandin-E synthase inhibitor | 0.105 0.024 CID_20908 | CID_20908 | |
| 0.018 | 0.259 | 0.056 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.018 CID_6195 0.056 0.01 CID_20908 | CID_20908 | |
| 0.013 | 0.255 | 0.073 | NMDA receptor glycine site agonist | 0.073 0.034 CID_20908 | CID_20908 | |
| 0.022 | 0.264 | 0.105 | Topoisomerase II beta inhibitor | 0.077 0.014 CID_6195 0.105 0.009 CID_20908 | CID_20908 | |
| 0.021 | 0.263 | 0.116 | Androgen antagonist | 0.116 0.035 CID_6195 0.102 0.045 CID_20908 | CID_6195 | |
| 0.053 | 0.297 | 0.233 | Glutamate release inhibitor | 0.101 0.041 CID_6195 0.233 0.004 CID_20908 | CID_20908 | |
| 0.005 | 0.251 | 0.051 | Sirtuin 2 inhibitor | 0.051 0.012 CID_20908 | CID_20908 | |
| 0.02 | 0.266 | 0.044 | Leukotriene C4 antagonist | 0.044 0.017 CID_20908 | CID_20908 | |
| 0.088 | 0.335 | 0.32 | Superoxide dismutase inhibitor | 0.208 0.108 CID_6443233 0.306 0.048 CID_6195 0.32 0.044 CID_20908 | CID_20908 | |
| 0.011 | 0.258 | 0.082 | Mannosidase inhibitor | 0.082 0.008 CID_20908 | CID_20908 | |
| 0.002 | 0.249 | 0.043 | G-protein-coupled receptor 120 agonist | 0.043 0.004 CID_20908 | CID_20908 | |
| 0.017 | 0.265 | 0.088 | Protein kinase C beta inhibitor | 0.088 0.021 CID_6195 0.082 0.027 CID_20908 | CID_6195 | |
| 0.008 | 0.256 | 0.075 | Ornithine carbamoyltransferase inhibitor | 0.052 0.037 CID_6195 0.075 0.024 CID_20908 | CID_20908 | |
| 0.048 | 0.296 | 0.158 | Antibacterial (Helicobacter pylori) | 0.158 0.04 CID_6195 0.156 0.041 CID_20908 | CID_6195 | |
| 0.093 | 0.342 | 0.352 | DNA synthesis inhibitor | 0.285 0.049 CID_6195 0.352 0.03 CID_20908 | CID_20908 | |
| 0.009 | 0.259 | 0.071 | Thromboxane A2 antagonist | 0.06 0.028 CID_6195 0.071 0.021 CID_20908 | CID_20908 | |
| 0.031 | 0.283 | 0.091 | Peroxisome proliferator-activated receptor gamma antagonist | 0.091 0.022 CID_6195 0.084 0.028 CID_20908 | CID_6195 | |
| 0.036 | 0.288 | 0.22 | GABA receptor agonist | 0.22 0.014 CID_6195 0.123 0.054 CID_20908 | CID_6195 | |
| 0.045 | 0.297 | 0.143 | Microtubule formation inhibitor | 0.112 0.07 CID_6195 0.143 0.041 CID_20908 | CID_20908 | |
| 0.046 | 0.299 | 0.125 | D-Ala-D-Ala ligase inhibitor | 0.11 0.02 CID_6195 0.125 0.011 CID_20908 | CID_20908 | |
| 0.018 | 0.27 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.058 0.041 CID_6195 0.077 0.019 CID_20908 | CID_20908 | |
| 0.047 | 0.3 | 0.125 | Cytokine production inhibitor | 0.125 0.084 CID_20908 | CID_20908 | |
| 0.03 | 0.284 | 0.066 | Leukotriene C antagonist | 0.066 0.018 CID_20908 | CID_20908 | |
| 0.042 | 0.296 | 0.202 | Granulocyte macrophage colony stimulating factor agonist | 0.202 0.003 CID_6195 0.161 0.004 CID_20908 | CID_6195 | |
| 0.002 | 0.257 | 0.011 | Integrin beta2 antagonist | 0.011 0.01 CID_6195 | CID_6195 | |
| 0.022 | 0.277 | 0.071 | Metalloproteinase-9 inhibitor | 0.071 0.054 CID_20908 | CID_20908 | |
| 0.025 | 0.28 | 0.121 | CD45 antagonist | 0.121 0.007 CID_6195 0.064 0.018 CID_20908 | CID_6195 | |
| 0.005 | 0.262 | 0.044 | 5-Alpha-reductase inhibitor | 0.044 0.022 CID_6195 | CID_6195 | |
| 0.009 | 0.267 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.01 CID_20908 | CID_20908 | |
| 0.005 | 0.262 | 0.038 | Prostaglandin agonist | 0.038 0.014 CID_20908 | CID_20908 | |
| 0.003 | 0.261 | 0.028 | Prostaglandin E2 agonist | 0.028 0.012 CID_20908 | CID_20908 | |
| 0.039 | 0.298 | 0.12 | Proteasome inhibitor | 0.105 0.081 CID_6195 0.12 0.065 CID_20908 | CID_20908 | |
| 0.031 | 0.29 | 0.193 | Creatine kinase inhibitor | 0.147 0.025 CID_6195 0.193 0.012 CID_20908 | CID_20908 | |
| 0.005 | 0.264 | 0.058 | Kainate receptor antagonist | 0.058 0.017 CID_6195 | CID_6195 | |
| 0.014 | 0.275 | 0.055 | Matrix metalloproteinase (membrane-type) inhibitor | 0.055 0.038 CID_20908 | CID_20908 | |
| 0.051 | 0.312 | 0.205 | Interleukin 8 antagonist | 0.205 0.012 CID_6195 0.105 0.086 CID_20908 | CID_6195 | |
| 0.026 | 0.288 | 0.129 | Interferon agonist | 0.129 0.014 CID_20908 | CID_20908 | |
| 0.029 | 0.291 | 0.161 | Aminopeptidase B inhibitor | 0.124 0.05 CID_6195 0.161 0.033 CID_20908 | CID_20908 | |
| 0.005 | 0.267 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 CID_20908 | CID_20908 | |
| 0.052 | 0.315 | 0.372 | Anesthetic general | 0.372 0.02 CID_6195 0.281 0.038 CID_20908 | CID_6195 | |
| 0.015 | 0.279 | 0.064 | Matrix metalloproteinase inhibitor | 0.064 0.049 CID_20908 | CID_20908 | |
| 0.04 | 0.305 | 0.09 | MDM2 inhibitor | 0.09 0.011 CID_20908 | CID_20908 | |
| 0.003 | 0.268 | 0.032 | AMPA 1 receptor antagonist | 0.032 0.019 CID_6195 | CID_6195 | |
| 0.014 | 0.279 | 0.166 | Biliverdin reductase inhibitor | 0.1 0.019 CID_6195 0.166 0.008 CID_20908 | CID_20908 | |
| 0.011 | 0.276 | 0.074 | Thromboxane antagonist | 0.059 0.033 CID_6195 0.074 0.024 CID_20908 | CID_20908 | |
| 0.016 | 0.281 | 0.115 | Nicotinic alpha4beta2 receptor antagonist | 0.086 0.044 CID_6195 0.115 0.02 CID_20908 | CID_20908 | |
| 0.006 | 0.272 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 CID_6195 | CID_6195 | |
| 0.006 | 0.273 | 0.033 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.033 0.026 CID_6195 | CID_6195 | |
| 0.034 | 0.302 | 0.18 | Mucolytic | 0.163 0.026 CID_6195 0.18 0.019 CID_20908 | CID_20908 | |
| 0.077 | 0.344 | 0.25 | Phospholipase C inhibitor | 0.25 0.025 CID_6195 0.226 0.031 CID_20908 | CID_6195 | |
| 0.026 | 0.294 | 0.105 | Interferon inducer | 0.105 0.011 CID_20908 | CID_20908 | |
| 0.036 | 0.306 | 0.324 | Triose-phosphate isomerase inhibitor | 0.182 0.013 CID_6195 0.324 0.004 CID_20908 | CID_20908 | |
| 0.008 | 0.278 | 0.026 | Toll-Like receptor 8 agonist | 0.026 0.006 CID_20908 | CID_20908 | |
| 0.005 | 0.275 | 0.047 | Farnesoid X receptor agonist | 0.047 0.017 CID_20908 | CID_20908 | |
| 0.018 | 0.289 | 0.056 | Carbonic anhydrase stimulant | 0.056 0.045 CID_20908 | CID_20908 | |
| 0.035 | 0.308 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.04 CID_6195 0.061 0.052 CID_20908 | CID_6195 | |
| 0.005 | 0.281 | 0.077 | Free fatty acid receptor 1 antagonist | 0.034 0.023 CID_6195 0.077 0.004 CID_20908 | CID_20908 | |
| 0.011 | 0.287 | 0.05 | Dihydrofolate reductase inhibitor | 0.05 0.019 CID_20908 | CID_20908 | |
| 0.007 | 0.285 | 0.143 | Carbonic anhydrase VB inhibitor | 0.143 0.009 CID_20908 | CID_20908 | |
| 0.021 | 0.298 | 0.079 | Beta adrenoreceptor antagonist | 0.079 0.028 CID_20908 | CID_20908 | |
| 0.103 | 0.38 | 0.274 | Insulysin inhibitor | 0.257 0.09 CID_6195 0.274 0.076 CID_20908 | CID_20908 | |
| 0.003 | 0.281 | 0.017 | Complement factor D inhibitor | 0.017 0.016 CID_20908 | CID_20908 | |
| 0.048 | 0.327 | 0.209 | Cell wall synthesis inhibitor | 0.209 0.027 CID_20908 | CID_20908 | |
| 0.023 | 0.304 | 0.205 | Topoisomerase I inhibitor | 0.205 0.025 CID_20908 | CID_20908 | |
| 0.019 | 0.3 | 0.057 | Epithelial sodium channel blocker | 0.057 0.034 CID_20908 | CID_20908 | |
| 0.037 | 0.321 | 0.071 | Prolactin release inhibitor | 0.071 0.021 CID_20908 | CID_20908 | |
| 0.066 | 0.35 | 0.149 | Pregnane X receptor agonist | 0.144 0.064 CID_6195 0.149 0.055 CID_20908 | CID_20908 | |
| 0.03 | 0.315 | 0.067 | Bcl-xL inhibitor | 0.067 0.025 CID_6195 0.064 0.03 CID_20908 | CID_6195 | |
| 0.017 | 0.302 | 0.125 | Carbonic anhydrase VA inhibitor | 0.125 0.017 CID_20908 | CID_20908 | |
| 0.005 | 0.291 | 0.093 | AMPA receptor antagonist | 0.093 0.014 CID_6195 0.054 0.028 CID_20908 | CID_6195 | |
| 0.042 | 0.329 | 0.213 | LIM domain kinase 1 inhibitor | 0.213 0.057 CID_6195 0.142 0.107 CID_20908 | CID_6195 | |
| 0.025 | 0.312 | 0.07 | Potassium channel (Tandem pore domain) blocker | 0.07 0.063 CID_6195 | CID_6195 | |
| 0.011 | 0.302 | 0.065 | Acetylcholine M5 receptor agonist | 0.065 0.05 CID_6195 | CID_6195 | |
| 0.006 | 0.297 | 0.057 | Glutamate (mGluR1) antagonist | 0.057 0.042 CID_6195 | CID_6195 | |
| 0.011 | 0.303 | 0.122 | Argininosuccinate synthase inhibitor | 0.089 0.022 CID_6195 0.122 0.015 CID_20908 | CID_20908 | |
| 0.034 | 0.327 | 0.092 | GABA B receptor agonist | 0.08 0.041 CID_6195 0.092 0.023 CID_20908 | CID_20908 | |
| 0.026 | 0.319 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 CID_20908 | CID_20908 | |
| 0.009 | 0.302 | 0.072 | Neutrophil collagenase inhibitor | 0.072 0.038 CID_20908 | CID_20908 | |
| 0.008 | 0.303 | 0.032 | Melatonin agonist | 0.032 0.023 CID_20908 | CID_20908 | |
| 0.043 | 0.339 | 0.191 | Phospholipase A2 inhibitor | 0.161 0.065 CID_6195 0.191 0.048 CID_20908 | CID_20908 | |
| 0.047 | 0.342 | 0.439 | Peroxidase inhibitor | 0.341 0.03 CID_6195 0.439 0.015 CID_20908 | CID_20908 | |
| 0.015 | 0.313 | 0.168 | Sphingosine 1-phosphate receptor 4 agonist | 0.168 0.006 CID_6195 0.139 0.011 CID_20908 | CID_6195 | |
| 0.022 | 0.322 | 0.163 | Purinergic P2X1 antagonist | 0.163 0.005 CID_6195 0.117 0.012 CID_20908 | CID_6195 | |
| 0.042 | 0.344 | 0.162 | DOPA decarboxylase inhibitor | 0.15 0.021 CID_6195 0.162 0.016 CID_20908 | CID_20908 | |
| 0.022 | 0.326 | 0.093 | Glutamate (mGluR7) antagonist | 0.093 0.015 CID_6195 0.09 0.018 CID_20908 | CID_6195 | |
| 0.011 | 0.316 | 0.072 | Nicotinic receptor alpha3 subunit antagonist | 0.072 0.015 CID_6195 0.04 0.036 CID_20908 | CID_6195 | |
| 0.012 | 0.318 | 0.137 | Carbamoyl phosphate synthetase inhibitor | 0.08 0.028 CID_6195 0.137 0.013 CID_20908 | CID_20908 | |
| 0.014 | 0.32 | 0.077 | Rho-associated kinase I inhibitor | 0.077 0.049 CID_6195 | CID_6195 | |
| 0.029 | 0.335 | 0.148 | Keratolytic | 0.069 0.066 CID_6195 0.148 0.015 CID_20908 | CID_20908 | |
| 0.017 | 0.324 | 0.051 | Lysine-specific demethylase 1A inhibitor | 0.051 0.042 CID_20908 | CID_20908 | |
| 0.023 | 0.333 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | 0.059 0.049 CID_6195 | CID_6195 | |
| 0.008 | 0.319 | 0.028 | Integrin alpha2beta1 antagonist | 0.028 0.015 CID_20908 | CID_20908 | |
| 0.013 | 0.325 | 0.144 | Carbonic anhydrase V inhibitor | 0.144 0.016 CID_20908 | CID_20908 | |
| 0.002 | 0.315 | 0.014 | Thromboxane A2 agonist | 0.014 0.013 CID_20908 | CID_20908 | |
| 0.02 | 0.335 | 0.162 | Expectorant | 0.142 0.039 CID_6195 0.162 0.031 CID_20908 | CID_20908 | |
| 0.034 | 0.349 | 0.124 | Nav1.3 sodium channel blocker | 0.124 0.069 CID_20908 | CID_20908 | |
| 0.002 | 0.318 | 0.026 | Kainate receptor 1 antagonist | 0.026 0.012 CID_6195 | CID_6195 | |
| 0.033 | 0.349 | 0.367 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.156 0.025 CID_6195 0.367 0.004 CID_20908 | CID_20908 | |
| 0.01 | 0.327 | 0.078 | Carbonic anhydrase XIV inhibitor | 0.078 0.017 CID_20908 | CID_20908 | |
| 0.042 | 0.359 | 0.172 | Cyclooxygenase 3 inhibitor | 0.172 0.032 CID_20908 | CID_20908 | |
| 0.013 | 0.331 | 0.054 | AICAR transformylase inhibitor | 0.043 0.032 CID_6195 0.054 0.018 CID_20908 | CID_20908 | |
| 0.027 | 0.344 | 0.208 | Cystathionine beta-synthase inhibitor | 0.161 0.036 CID_6195 0.208 0.023 CID_20908 | CID_20908 | |
| 0.004 | 0.322 | 0.082 | Sodium/glucose cotransporter 2 inhibitor | 0.082 0.004 CID_20908 | CID_20908 | |
| 0.012 | 0.333 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.022 CID_6195 0.031 0.028 CID_20908 | CID_6195 | |
| 0.009 | 0.33 | 0.051 | Liver X receptor agonist | 0.051 0.022 CID_20908 | CID_20908 | |
| 0.008 | 0.329 | 0.026 | ICAM 1 antagonist | 0.026 0.011 CID_6195 0.024 0.014 CID_20908 | CID_6195 | |
| 0.022 | 0.344 | 0.05 | Heme oxygenase inhibitor | 0.044 0.025 CID_6195 0.05 0.013 CID_20908 | CID_20908 | |
| 0.014 | 0.337 | 0.057 | Beta 2 adrenoreceptor antagonist | 0.057 0.027 CID_20908 | CID_20908 | |
| 0.085 | 0.409 | 0.244 | Immunomodulator | 0.244 0.12 CID_20908 | CID_20908 | |
| 0.008 | 0.332 | 0.041 | Thymidine phosphorylase inhibitor | 0.041 0.006 CID_20908 | CID_20908 | |
| 0.013 | 0.337 | 0.065 | Beta 1 adrenoreceptor antagonist | 0.065 0.031 CID_20908 | CID_20908 | |
| 0.004 | 0.328 | 0.027 | Beta 1 adrenoreceptor agonist | 0.027 0.01 CID_20908 | CID_20908 | |
| 0.007 | 0.33 | 0.131 | Aromatase inhibitor | 0.131 0.016 CID_6195 0.094 0.023 CID_20908 | CID_6195 | |
| 0.056 | 0.38 | 0.137 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.137 0.127 CID_6195 | CID_6195 | |
| 0.013 | 0.339 | 0.178 | Catalase inhibitor | 0.111 0.035 CID_6195 0.178 0.02 CID_20908 | CID_20908 | |
| 0.003 | 0.329 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.019 0.014 CID_6195 | CID_6195 | |
| 0.001 | 0.328 | 0.013 | Glutamate (mGluR6) agonist | 0.013 0.008 CID_20908 | CID_20908 | |
| 0.004 | 0.331 | 0.05 | Glutamate (mGluR2) antagonist | 0.05 0.008 CID_20908 | CID_20908 | |
| 0.011 | 0.339 | 0.077 | Adenosine deaminase inhibitor | 0.077 0.01 CID_20908 | CID_20908 | |
| 0.005 | 0.334 | 0.063 | Estrogen agonist | 0.063 0.029 CID_20908 | CID_20908 | |
| 0.028 | 0.357 | 0.1 | Glutathione S-transferase inhibitor | 0.1 0.038 CID_20908 | CID_20908 | |
| 0.013 | 0.343 | 0.067 | GABA B receptor antagonist | 0.067 0.009 CID_6195 0.043 0.03 CID_20908 | CID_6195 | |
| 0.02 | 0.349 | 0.195 | Alcohol dehydrogenase inhibitor | 0.195 0.013 CID_6195 0.164 0.017 CID_20908 | CID_6195 | |
| 0.029 | 0.36 | 0.111 | Glutamate (mGluR6) antagonist | 0.084 0.02 CID_6195 0.111 0.007 CID_20908 | CID_20908 | |
| 0.011 | 0.345 | 0.061 | Potassium channel (Inward rectifier) blocker | 0.061 0.023 CID_20908 | CID_20908 | |
| 0.014 | 0.348 | 0.057 | Glutamate (mGluR8) agonist | 0.043 0.018 CID_6195 0.057 0.008 CID_20908 | CID_20908 | |
| 0.005 | 0.343 | 0.066 | Sodium/glucose cotransporter inhibitor | 0.066 0.004 CID_20908 | CID_20908 | |
| 0.01 | 0.35 | 0.044 | AMPA 4 receptor antagonist | 0.044 0.02 CID_6195 0.038 0.031 CID_20908 | CID_6195 | |
| 0.006 | 0.346 | 0.029 | LFA antagonist | 0.029 0.017 CID_6195 0.025 0.024 CID_20908 | CID_6195 | |
| 0.01 | 0.352 | 0.038 | Glutamate (mGluR3) agonist | 0.038 0.012 CID_6195 0.037 0.013 CID_20908 | CID_6195 | |
| 0.009 | 0.353 | 0.1 | TRPA1 antagonist | 0.1 0.017 CID_6195 | CID_6195 | |
| 0.084 | 0.428 | 0.341 | RNA-directed DNA polymerase inhibitor | 0.22 0.074 CID_6195 0.341 0.025 CID_20908 | CID_20908 | |
| 0.037 | 0.382 | 0.187 | MAP kinase kinase 2 inhibitor | 0.187 0.09 CID_20908 | CID_20908 | |
| 0.004 | 0.349 | 0.076 | Kainate receptor 2 antagonist | 0.076 0.007 CID_6195 | CID_6195 | |
| 0.021 | 0.368 | 0.146 | Glucosylceramidase inhibitor | 0.146 0.004 CID_20908 | CID_20908 | |
| 0.018 | 0.366 | 0.092 | 5 Hydroxytryptamine 3 agonist | 0.092 0.019 CID_6195 | CID_6195 | |
| 0.022 | 0.372 | 0.119 | Myeloperoxidase inhibitor | 0.119 0.02 CID_20908 | CID_20908 | |
| 0.01 | 0.36 | 0.061 | Sphingosine kinase 1 inhibitor | 0.061 0.009 CID_20908 | CID_20908 | |
| 0.014 | 0.364 | 0.138 | Leukotriene synthesis inhibitor | 0.138 0.011 CID_20908 | CID_20908 | |
| 0.01 | 0.36 | 0.106 | Glutamate receptor agonist | 0.106 0.033 CID_6195 0.082 0.051 CID_20908 | CID_6195 | |
| 0.037 | 0.387 | 0.225 | Estrogen antagonist | 0.225 0.01 CID_6195 0.123 0.05 CID_20908 | CID_6195 | |
| 0.033 | 0.384 | 0.096 | MAP kinase kinase 7 inhibitor | 0.073 0.07 CID_6195 0.096 0.017 CID_20908 | CID_20908 | |
| 0.033 | 0.384 | 0.208 | Carbonic anhydrase III inhibitor | 0.086 0.081 CID_6195 0.208 0.015 CID_20908 | CID_20908 | |
| 0.004 | 0.355 | 0.07 | Glutamate (mGluR group II) antagonist | 0.07 0.009 CID_20908 | CID_20908 | |
| 0.045 | 0.398 | 0.2 | Sphingosine 1-phosphate receptor 4 antagonist | 0.2 0.009 CID_6195 0.188 0.012 CID_20908 | CID_6195 | |
| 0.032 | 0.386 | 0.122 | Electrolyte absorption antagonist | 0.117 0.038 CID_6195 0.122 0.035 CID_20908 | CID_20908 | |
| 0.007 | 0.363 | 0.041 | Glutamate (mGluR5) agonist | 0.041 0.04 CID_20908 | CID_20908 | |
| 0.011 | 0.367 | 0.063 | Alpha adrenoreceptor agonist | 0.063 0.052 CID_20908 | CID_20908 | |
| 0.026 | 0.386 | 0.123 | Interleukin 1 beta converting enzyme inhibitor | 0.109 0.047 CID_6195 0.123 0.033 CID_20908 | CID_20908 | |
| 0.028 | 0.387 | 0.157 | Beta glucuronidase inhibitor | 0.157 0.022 CID_6195 0.114 0.051 CID_20908 | CID_6195 | |
| 0.058 | 0.417 | 0.225 | Interferon gamma antagonist | 0.225 0.033 CID_6195 0.207 0.038 CID_20908 | CID_6195 | |
| 0.006 | 0.366 | 0.039 | NMDA receptor subunit 3B antagonist | 0.039 0.037 CID_20908 | CID_20908 | |
| 0.011 | 0.372 | 0.059 | Collagenase 3 inhibitor | 0.059 0.042 CID_20908 | CID_20908 | |
| 0.023 | 0.384 | 0.058 | Ryanodine receptor antagonist | 0.058 0.043 CID_20908 | CID_20908 | |
| 0.013 | 0.375 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | 0.056 0.033 CID_20908 | CID_20908 | |
| 0.019 | 0.383 | 0.066 | Dihydroorotate oxidase inhibitor | 0.061 0.028 CID_6195 0.066 0.021 CID_20908 | CID_20908 | |
| 0.003 | 0.368 | 0.06 | Uridine phosphorylase inhibitor | 0.06 0.005 CID_20908 | CID_20908 | |
| 0.121 | 0.486 | 0.215 | MAP kinase kinase 3 inhibitor | 0.215 0.085 CID_6443233 | CID_6443233 | |
| 0.01 | 0.377 | 0.039 | Integrin alpha2 antagonist | 0.039 0.022 CID_20908 | CID_20908 | |
| 0.013 | 0.381 | 0.104 | Sphingosine kinase 2 inhibitor | 0.104 0.007 CID_20908 | CID_20908 | |
| 0.016 | 0.385 | 0.067 | Potassium channel (ATP-sensitive) blocker | 0.067 0.047 CID_20908 | CID_20908 | |
| 0.026 | 0.395 | 0.101 | MAP kinase kinase 1 inhibitor | 0.101 0.055 CID_20908 | CID_20908 | |
| 0.01 | 0.38 | 0.063 | Dihydroorotase inhibitor | 0.051 0.023 CID_6195 0.063 0.015 CID_20908 | CID_20908 | |
| 0.007 | 0.38 | 0.054 | Liver X receptor alpha antagonist | 0.054 0.005 CID_20908 | CID_20908 | |
| 0.033 | 0.406 | 0.159 | Interleukin 1b antagonist | 0.159 0.034 CID_20908 | CID_20908 | |
| 0.036 | 0.411 | 0.12 | Nav1.1 sodium channel blocker | 0.12 0.048 CID_20908 | CID_20908 | |
| 0.045 | 0.422 | 0.227 | Hexokinase inhibitor | 0.129 0.105 CID_6195 0.227 0.023 CID_20908 | CID_20908 | |
| 0.006 | 0.383 | 0.056 | Calcium release-activated channel blocker | 0.056 0.008 CID_6195 | CID_6195 | |
| 0.009 | 0.387 | 0.095 | Benzodiazepine agonist | 0.095 0.029 CID_6195 | CID_6195 | |
| 0.045 | 0.425 | 0.364 | Interleukin agonist | 0.177 0.142 CID_6195 0.364 0.025 CID_20908 | CID_20908 | |
| 0.005 | 0.386 | 0.035 | Dopamine D3 agonist | 0.035 0.034 CID_6195 | CID_6195 | |
| 0.04 | 0.422 | 0.085 | Ca(v)3.1 blocker | 0.085 0.047 CID_6443233 | CID_6443233 | |
| 0.024 | 0.408 | 0.193 | Carbonic anhydrase VI inhibitor | 0.193 0.014 CID_20908 | CID_20908 | |
| 0.008 | 0.393 | 0.05 | Pim-2 kinase inhibitor | 0.05 0.046 CID_6195 | CID_6195 | |
| 0.005 | 0.391 | 0.115 | Beta tubulin antagonist | 0.115 0.019 CID_6195 | CID_6195 | |
| 0.006 | 0.392 | 0.043 | Glutamate (mGluR group I) agonist | 0.043 0.039 CID_20908 | CID_20908 | |
| 0.035 | 0.422 | 0.128 | NADPH oxidase inhibitor | 0.128 0.074 CID_20908 | CID_20908 | |
| 0.04 | 0.428 | 0.237 | Free radical scavenger | 0.237 0.074 CID_6195 0.162 0.131 CID_20908 | CID_6195 | |
| 0.007 | 0.394 | 0.063 | Glutamate (mGluR3) antagonist | 0.063 0.007 CID_20908 | CID_20908 | |
| 0.006 | 0.395 | 0.057 | Toll-Like receptor 8 antagonist | 0.057 0.034 CID_20908 | CID_20908 | |
| 0.033 | 0.422 | 0.134 | Thioredoxin reductase inhibitor | 0.084 0.051 CID_6195 0.134 0.013 CID_20908 | CID_20908 | |
| 0.037 | 0.426 | 0.13 | Interleukin 1 antagonist | 0.13 0.076 CID_20908 | CID_20908 | |
| 0.011 | 0.401 | 0.09 | Sphingosine kinase inhibitor | 0.09 0.01 CID_20908 | CID_20908 | |
| 0.052 | 0.442 | 0.111 | Factor V inhibitor | 0.111 0.05 CID_6195 | CID_6195 | |
| 0.004 | 0.395 | 0.044 | HCV NS5B polymerase inhibitor | 0.044 0.012 CID_20908 | CID_20908 | |
| 0.028 | 0.42 | 0.111 | Bile acid receptor antagonist | 0.111 0.03 CID_20908 | CID_20908 | |
| 0.01 | 0.402 | 0.052 | Protein kinase C theta inhibitor | 0.052 0.05 CID_6195 | CID_6195 | |
| 0.092 | 0.485 | 0.295 | Nitric-oxide synthase stimulant | 0.216 0.065 CID_6195 0.295 0.013 CID_20908 | CID_20908 | |
| 0.016 | 0.409 | 0.052 | Fatty acid synthase inhibitor | 0.052 0.048 CID_20908 | CID_20908 | |
| 0.053 | 0.449 | 0.223 | CF transmembrane conductance regulator agonist | 0.165 0.052 CID_6195 0.223 0.012 CID_20908 | CID_20908 | |
| 0.014 | 0.411 | 0.052 | Beta adrenoreceptor agonist | 0.052 0.014 CID_20908 | CID_20908 | |
| 0.037 | 0.434 | 0.111 | Glutamate (mGluR7) agonist | 0.099 0.061 CID_6195 0.111 0.04 CID_20908 | CID_20908 | |
| 0.056 | 0.458 | 0.338 | Transcription factor NF kappa B inhibitor | 0.338 0.081 CID_6195 0.315 0.087 CID_20908 | CID_6195 | |
| 0.019 | 0.424 | 0.192 | GABA A receptor agonist | 0.192 0.011 CID_6195 0.092 0.046 CID_20908 | CID_6195 | |
| 0.059 | 0.464 | 0.286 | Hypoxia-inducible factor 1 alpha inhibitor | 0.209 0.142 CID_6195 0.286 0.072 CID_20908 | CID_20908 | |
| 0.033 | 0.44 | 0.18 | Heat shock protein 90 antagonist | 0.18 0.049 CID_6195 0.118 0.117 CID_20908 | CID_6195 | |
| 0.032 | 0.439 | 0.259 | Mannose-6-phosphate isomerase inhibitor | 0.244 0.014 CID_6195 0.259 0.01 CID_20908 | CID_20908 | |
| 0.06 | 0.468 | 0.167 | Sphingosine 1-phosphate receptor 5 antagonist | 0.129 0.102 CID_6195 0.167 0.037 CID_20908 | CID_20908 | |
| 0.016 | 0.425 | 0.065 | Heparanase inhibitor | 0.065 0.016 CID_20908 | CID_20908 | |
| 0.016 | 0.427 | 0.157 | Carbonic anhydrase XIII inhibitor | 0.113 0.032 CID_6195 0.157 0.02 CID_20908 | CID_20908 | |
| 0.075 | 0.486 | 0.197 | Sodium/bile acid cotransporter inhibitor | 0.197 0.192 CID_20908 | CID_20908 | |
| 0.022 | 0.436 | 0.138 | 5 Hydroxytryptamine 3A agonist | 0.138 0.043 CID_6195 0.104 0.072 CID_20908 | CID_6195 | |
| 0.014 | 0.428 | 0.068 | I kappa B kinase 2 inhibitor | 0.068 0.034 CID_20908 | CID_20908 | |
| 0.005 | 0.42 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | 0.041 0.02 CID_6195 | CID_6195 | |
| 0.017 | 0.432 | 0.124 | Ca(v)2.2 blocker | 0.124 0.037 CID_6195 | CID_6195 | |
| 0.018 | 0.434 | 0.089 | Mediator release inhibitor | 0.089 0.083 CID_20908 | CID_20908 | |
| 0.011 | 0.426 | 0.306 | Histidine decarboxylase inhibitor | 0.276 0.007 CID_6195 0.306 0.006 CID_20908 | CID_20908 | |
| 0.014 | 0.433 | 0.062 | Aryl hydrocarbon receptor antagonist | 0.061 0.051 CID_6195 0.062 0.049 CID_20908 | CID_20908 | |
| 0.059 | 0.478 | 0.309 | Antithrombotic | 0.309 0.082 CID_20908 | CID_20908 | |
| 0.006 | 0.434 | 0.045 | Nicotinic acid receptor agonist | 0.044 0.017 CID_6195 0.045 0.017 CID_20908 | CID_20908 | |
| 0.019 | 0.448 | 0.16 | Protein kinase C gamma inhibitor | 0.16 0.026 CID_6195 0.158 0.027 CID_20908 | CID_6195 | |
| 0.002 | 0.433 | 0.017 | Nicotinic acid receptor 1 antagonist | 0.017 0.013 CID_20908 | CID_20908 | |
| 0.003 | 0.439 | 0.03 | Glutamate (mGluR1a) agonist | 0.03 0.009 CID_6195 0.029 0.009 CID_20908 | CID_6195 | |
| 0.046 | 0.481 | 0.265 | Cyclic AMP phosphodiesterase inhibitor | 0.265 0.057 CID_20908 | CID_20908 | |
| 0.018 | 0.453 | 0.097 | Potassium channel (Ca-activated) activator | 0.097 0.058 CID_20908 | CID_20908 | |
| 0.028 | 0.466 | 0.114 | Nav1.4 sodium channel blocker | 0.114 0.058 CID_20908 | CID_20908 | |
| 0.012 | 0.449 | 0.128 | Protein kinase C zeta inhibitor | 0.128 0.028 CID_6195 0.107 0.043 CID_20908 | CID_6195 | |
| 0.038 | 0.476 | 0.236 | Non-steroidal antiinflammatory agent | 0.236 0.049 CID_20908 | CID_20908 | |
| 0.007 | 0.446 | 0.102 | Xanthine dehydrogenase inhibitor | 0.086 0.021 CID_6195 0.102 0.015 CID_20908 | CID_20908 | |
| 0.008 | 0.449 | 0.189 | Monophenol monooxygenase inhibitor | 0.189 0.036 CID_6195 0.176 0.039 CID_20908 | CID_6195 | |
| 0.096 | 0.538 | 0.461 | 5 Hydroxytryptamine release inhibitor | 0.397 0.08 CID_6195 0.461 0.047 CID_20908 | CID_20908 | |
| 0.003 | 0.446 | 0.063 | Urate transporter 1 inhibitor | 0.063 0.013 CID_20908 | CID_20908 | |
| 0.016 | 0.459 | 0.116 | Macrophage migration inhibitory factor inhibitor | 0.116 0.027 CID_6195 0.108 0.031 CID_20908 | CID_6195 | |
| 0.045 | 0.489 | 0.154 | DNA repair enzyme inhibitor | 0.111 0.093 CID_6195 0.154 0.028 CID_20908 | CID_20908 | |
| 0.003 | 0.449 | 0.039 | Orexin receptor 2 antagonist | 0.039 0.022 CID_6195 | CID_6195 | |
| 0.035 | 0.482 | 0.151 | Sphingosine 1-phosphate receptor 2 antagonist | 0.151 0.04 CID_20908 | CID_20908 | |
| 0.027 | 0.477 | 0.11 | Bromodomain-containing protein 2 inhibitor | 0.11 0.03 CID_20908 | CID_20908 | |
| 0.043 | 0.497 | 0.36 | 3C-like protease (Human coronavirus) inhibitor | 0.36 0.005 CID_6195 0.193 0.056 CID_20908 | CID_6195 | |
| 0.005 | 0.459 | 0.043 | Leukocyte elastase inhibitor | 0.043 0.029 CID_6195 | CID_6195 | |
| 0.028 | 0.482 | 0.13 | Activin receptor-like kinase 2 inhibitor | 0.13 0.085 CID_20908 | CID_20908 | |
| 0.04 | 0.495 | 0.312 | 12-Lipoxygenase inhibitor | 0.285 0.089 CID_6195 0.312 0.073 CID_20908 | CID_20908 | |
| 0.018 | 0.473 | 0.112 | Toll-Like receptor 9 antagonist | 0.112 0.095 CID_6195 | CID_6195 | |
| 0.014 | 0.471 | 0.102 | Urease inhibitor | 0.102 0.065 CID_20908 | CID_20908 | |
| 0.023 | 0.482 | 0.174 | Toll-Like receptor antagonist | 0.174 0.041 CID_6195 0.122 0.081 CID_20908 | CID_6195 | |
| 0.005 | 0.467 | 0.029 | Thyroid hormone agonist | 0.029 0.014 CID_20908 | CID_20908 | |
| 0.01 | 0.476 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.051 0.028 CID_6195 | CID_6195 | |
| 0.057 | 0.524 | 0.454 | Histamine release inhibitor | 0.314 0.116 CID_6195 0.454 0.048 CID_20908 | CID_20908 | |
| 0.014 | 0.481 | 0.115 | MAP kinase kinase inhibitor | 0.115 0.079 CID_20908 | CID_20908 | |
| 0.004 | 0.472 | 0.075 | Phosphorylase inhibitor | 0.054 0.028 CID_6195 0.075 0.018 CID_20908 | CID_20908 | |
| 0.01 | 0.479 | 0.054 | Potassium channel (Inward rectifier) activator | 0.054 0.029 CID_6195 0.046 0.045 CID_20908 | CID_6195 | |
| 0.003 | 0.475 | 0.023 | Kynurenine 3 monooxygenase inhibitor | 0.023 0.022 CID_20908 | CID_20908 | |
| 0.023 | 0.495 | 0.188 | Xanthine oxidase inhibitor | 0.188 0.022 CID_6195 0.16 0.031 CID_20908 | CID_6195 | |
| 0.029 | 0.503 | 0.268 | Calpain inhibitor | 0.268 0.049 CID_6195 0.181 0.134 CID_20908 | CID_6195 | |
| 0.012 | 0.486 | 0.076 | Cyclin D1 inhibitor | 0.076 0.022 CID_20908 | CID_20908 | |
| 0.005 | 0.48 | 0.045 | Nicotinic receptor alpha4 subunit antagonist | 0.045 0.044 CID_6195 | CID_6195 | |
| 0.07 | 0.55 | 0.371 | Calcium channel activator | 0.301 0.091 CID_6195 0.371 0.037 CID_20908 | CID_20908 | |
| 0.026 | 0.505 | 0.111 | mTOR complex 2 inhibitor | 0.111 0.023 CID_20908 | CID_20908 | |
| 0.034 | 0.517 | 0.29 | Lipoxygenase inhibitor | 0.196 0.145 CID_6195 0.29 0.076 CID_20908 | CID_20908 | |
| 0.011 | 0.494 | 0.147 | Adrenaline agonist | 0.147 0.015 CID_20908 | CID_20908 | |
| 0.01 | 0.493 | 0.068 | CDC25A inhibitor | 0.068 0.06 CID_20908 | CID_20908 | |
| 0.015 | 0.5 | 0.128 | DNA intercalator | 0.128 0.053 CID_20908 | CID_20908 | |
| 0.032 | 0.518 | 0.15 | DNA methylase inhibitor | 0.15 0.117 CID_20908 | CID_20908 | |
| 0.019 | 0.505 | 0.145 | AMP-activated protein kinase stimulant | 0.092 0.083 CID_6195 0.145 0.031 CID_20908 | CID_20908 | |
| 0.011 | 0.498 | 0.073 | Orexin receptor antagonist | 0.073 0.036 CID_6195 | CID_6195 | |
| 0.015 | 0.504 | 0.075 | Caspase 7 inhibitor | 0.075 0.073 CID_20908 | CID_20908 | |
| 0.014 | 0.504 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.027 CID_6195 | CID_6195 | |
| 0.019 | 0.509 | 0.075 | Phosphodiesterase 1C inhibitor | 0.075 0.024 CID_20908 | CID_20908 | |
| 0.021 | 0.512 | 0.174 | I kappa B kinase epsilon inhibitor | 0.174 0.095 CID_20908 | CID_20908 | |
| 0.022 | 0.514 | 0.077 | Falcipain 2 inhibitor | 0.077 0.073 CID_6195 | CID_6195 | |
| 0.013 | 0.507 | 0.086 | Orexin receptor 1 antagonist | 0.086 0.026 CID_6195 | CID_6195 | |
| 0.022 | 0.519 | 0.08 | Falcipain inhibitor | 0.08 0.074 CID_6195 | CID_6195 | |
| 0.025 | 0.523 | 0.226 | Heat shock protein 90 alpha antagonist | 0.226 0.036 CID_6195 | CID_6195 | |
| 0.012 | 0.512 | 0.065 | Glutamate (mGluR group III) antagonist | 0.065 0.011 CID_6195 0.05 0.02 CID_20908 | CID_6195 | |
| 0.013 | 0.512 | 0.078 | I kappa B kinase inhibitor | 0.078 0.063 CID_20908 | CID_20908 | |
| 0.003 | 0.503 | 0.032 | Prostaglandin EP3 antagonist | 0.032 0.019 CID_20908 | CID_20908 | |
| 0.008 | 0.509 | 0.047 | Diacylglycerol O-acyltransferase inhibitor | 0.047 0.04 CID_20908 | CID_20908 | |
| 0.013 | 0.514 | 0.069 | Glutamate (mGluR4) antagonist | 0.069 0.01 CID_6195 0.047 0.024 CID_20908 | CID_6195 | |
| 0.039 | 0.543 | 0.192 | Tumour necrosis factor antagonist | 0.192 0.058 CID_20908 | CID_20908 | |
| 0.044 | 0.556 | 0.253 | Antiobesity | 0.253 0.154 CID_20908 | CID_20908 | |
| 0.007 | 0.519 | 0.108 | Pim-3 kinase inhibitor | 0.108 0.038 CID_6195 | CID_6195 | |
| 0.035 | 0.555 | 0.217 | Transcription factor STAT3 inhibitor | 0.217 0.114 CID_20908 | CID_20908 | |
| 0.004 | 0.526 | 0.039 | Purinergic P2Y antagonist | 0.039 0.038 CID_6195 | CID_6195 | |
| 0.038 | 0.566 | 0.252 | Hepatoprotectant | 0.15 0.11 CID_6195 0.252 0.043 CID_20908 | CID_20908 | |
| 0.005 | 0.536 | 0.135 | Prostaglandin EP2 antagonist | 0.135 0.012 CID_20908 | CID_20908 | |
| 0.024 | 0.557 | 0.377 | Amylase inhibitor | 0.155 0.062 CID_6195 0.377 0.011 CID_20908 | CID_20908 | |
| 0.015 | 0.55 | 0.135 | Caspase 3 inhibitor | 0.135 0.041 CID_6195 0.117 0.064 CID_20908 | CID_6195 | |
| 0.003 | 0.538 | 0.038 | G protein-coupled receptor agonist | 0.038 0.027 CID_20908 | CID_20908 | |
| 0.021 | 0.556 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.028 CID_20908 | CID_20908 | |
| 0.018 | 0.556 | 0.19 | Anticonvulsant | 0.166 0.111 CID_6195 0.19 0.09 CID_20908 | CID_20908 | |
| 0.007 | 0.549 | 0.041 | MAP3K5 inhibitor | 0.041 0.023 CID_20908 | CID_20908 | |
| 0.013 | 0.554 | 0.115 | Glucose-6-phosphate translocase inhibitor | 0.115 0.005 CID_6195 | CID_6195 | |
| 0.031 | 0.573 | 0.154 | Focal adhesion kinase 2 inhibitor | 0.154 0.124 CID_6195 | CID_6195 | |
| 0.003 | 0.545 | 0.02 | Calcium-sensing receptor antagonist | 0.02 0.008 CID_6195 | CID_6195 | |
| 0.03 | 0.573 | 0.126 | Transcription factor NF kappa B stimulant | 0.126 0.023 CID_20908 | CID_20908 | |
| 0.01 | 0.554 | 0.079 | Purinergic P2X4 antagonist | 0.079 0.007 CID_6195 0.046 0.032 CID_20908 | CID_6195 | |
| 0.011 | 0.556 | 0.051 | Aggrecanase 1 inhibitor | 0.051 0.013 CID_20908 | CID_20908 | |
| 0.019 | 0.573 | 0.128 | Nav1.5 sodium channel blocker | 0.128 0.045 CID_20908 | CID_20908 | |
| 0.094 | 0.652 | 0.567 | Calcium channel L-type activator | 0.235 0.222 CID_6195 0.567 0.01 CID_20908 | CID_20908 | |
| 0.016 | 0.574 | 0.058 | Phosphodiesterase 1B inhibitor | 0.058 0.044 CID_20908 | CID_20908 | |
| 0.033 | 0.596 | 0.196 | Histone acetyltransferase inhibitor | 0.196 0.076 CID_6195 0.166 0.118 CID_20908 | CID_6195 | |
| 0.011 | 0.578 | 0.168 | Cytidine deaminase inhibitor | 0.168 0.063 CID_20908 | CID_20908 | |
| 0.004 | 0.573 | 0.03 | Prostaglandin D2 agonist | 0.03 0.022 CID_20908 | CID_20908 | |
| 0.02 | 0.59 | 0.148 | DNA methyltransferase I inhibitor | 0.14 0.115 CID_6195 0.148 0.107 CID_20908 | CID_20908 | |
| 0.004 | 0.575 | 0.064 | Nav1.7 sodium channel blocker | 0.064 0.051 CID_20908 | CID_20908 | |
| 0.036 | 0.607 | 0.256 | Transcription factor STAT inhibitor | 0.256 0.083 CID_6195 0.207 0.128 CID_20908 | CID_6195 | |
| 0.007 | 0.579 | 0.147 | 5-Lipoxygenase inhibitor | 0.147 0.039 CID_20908 | CID_20908 | |
| 0.007 | 0.58 | 0.061 | Bcl2 antagonist | 0.061 0.053 CID_6195 0.059 0.057 CID_20908 | CID_6195 | |
| 0.035 | 0.608 | 0.288 | Immunosuppressant | 0.288 0.123 CID_20908 | CID_20908 | |
| 0.004 | 0.586 | 0.096 | Antineoplastic antibiotic | 0.096 0.048 CID_6195 | CID_6195 | |
| 0.013 | 0.596 | 0.189 | Alkaline phosphatase inhibitor | 0.189 0.038 CID_6195 0.112 0.096 CID_20908 | CID_6195 | |
| 0.011 | 0.596 | 0.498 | Aryl hydrocarbon receptor agonist | 0.498 0.024 CID_6195 0.215 0.094 CID_20908 | CID_6195 | |
| 0.004 | 0.595 | 0.094 | Dihydroorotate dehydrogenase inhibitor | 0.063 0.026 CID_6195 0.094 0.013 CID_20908 | CID_20908 | |
| 0.008 | 0.599 | 0.139 | Sodium channel (voltage-gated) blocker | 0.139 0.064 CID_20908 | CID_20908 | |
| 0.038 | 0.63 | 0.159 | MAP kinase 3 inhibitor | 0.159 0.055 CID_20908 | CID_20908 | |
| 0.027 | 0.622 | 0.27 | 15-Lipoxygenase inhibitor | 0.27 0.149 CID_6195 0.252 0.163 CID_20908 | CID_6195 | |
| 0.004 | 0.607 | 0.036 | AMPA receptor agonist | 0.036 0.024 CID_20908 | CID_20908 | |
| 0.005 | 0.608 | 0.053 | Prostaglandin antagonist | 0.053 0.037 CID_20908 | CID_20908 | |
| 0.009 | 0.618 | 0.109 | Sodium channel blocker | 0.109 0.099 CID_20908 | CID_20908 | |
| 0.028 | 0.64 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.067 CID_6195 | CID_6195 | |
| 0.021 | 0.637 | 0.367 | Calpain 2 inhibitor | 0.367 0.078 CID_6195 | CID_6195 | |
| 0.01 | 0.627 | 0.273 | Estrogen receptor beta antagonist | 0.273 0.006 CID_6195 0.109 0.048 CID_20908 | CID_6195 | |
| 0.019 | 0.636 | 0.235 | Vasodilator | 0.235 0.078 CID_20908 | CID_20908 | |
| 0.009 | 0.627 | 0.225 | Purinergic P2X2 antagonist | 0.225 0.004 CID_6195 | CID_6195 | |
| 0.017 | 0.645 | 0.084 | Phosphodiesterase I inhibitor | 0.084 0.07 CID_20908 | CID_20908 | |
| 0.004 | 0.64 | 0.041 | Purinergic P2X3 antagonist | 0.04 0.017 CID_6195 0.041 0.016 CID_20908 | CID_20908 | |
| 0.006 | 0.642 | 0.076 | HIV-1 integrase inhibitor | 0.076 0.042 CID_6195 | CID_6195 | |
| 0.022 | 0.669 | 0.239 | Tumour necrosis factor alpha release inhibitor | 0.239 0.08 CID_20908 | CID_20908 | |
| 0.009 | 0.665 | 0.255 | Pyruvate kinase inhibitor | 0.255 0.06 CID_6195 | CID_6195 | |
| 0.052 | 0.713 | 0.15 | Cyclin-dependent kinase 3 inhibitor | 0.15 0.095 CID_20908 | CID_20908 | |
| 0.004 | 0.667 | 0.06 | Nicotinic receptor beta4 subunit antagonist | 0.06 0.012 CID_6195 | CID_6195 | |
| 0.009 | 0.675 | 0.22 | Prostaglandin dehydrogenase inhibitor | 0.22 0.144 CID_6195 0.209 0.151 CID_20908 | CID_6195 | |
| 0.017 | 0.686 | 0.119 | Farnesoid X receptor antagonist | 0.119 0.106 CID_20908 | CID_20908 | |
| 0.006 | 0.691 | 0.194 | CDC25B inhibitor | 0.194 0.005 CID_6195 0.062 0.048 CID_20908 | CID_6195 | |
| 0.005 | 0.694 | 0.039 | Purinergic P2Y14 antagonist | 0.039 0.012 CID_20908 | CID_20908 | |
| 0.023 | 0.715 | 0.254 | Transcription factor inhibitor | 0.254 0.184 CID_6195 | CID_6195 | |
| 0.013 | 0.711 | 0.227 | Angiogenesis stimulant | 0.227 0.081 CID_20908 | CID_20908 | |
| 0.015 | 0.713 | 0.188 | Hemostatic | 0.188 0.038 CID_20908 | CID_20908 | |
| 0.006 | 0.715 | 0.131 | Tubulin antagonist | 0.131 0.07 CID_6195 | CID_6195 | |
| 0.005 | 0.717 | 0.082 | Histone deacetylase SIRT2 inhibitor | 0.082 0.044 CID_20908 | CID_20908 | |
| 0.004 | 0.726 | 0.108 | Catechol O-methyltransferase inhibitor | 0.108 0.005 CID_6195 | CID_6195 | |
| 0.005 | 0.74 | 0.161 | Alpha tubulin antagonist | 0.161 0.008 CID_6195 | CID_6195 | |
| 0.01 | 0.749 | 0.035 | Glutamate (mGluR8) antagonist | 0.035 0.025 CID_20908 | CID_20908 | |
| 0.02 | 0.781 | 0.112 | Interleukin 4 antagonist | 0.112 0.098 CID_20908 | CID_20908 | |
| 0.028 | 0.791 | 0.147 | NOS3 expression enhancer | 0.147 0.076 CID_20908 | CID_20908 | |
| 0.008 | 0.773 | 0.191 | Thioredoxin glutathione reductase inhibitor | 0.191 0.18 CID_6195 | CID_6195 | |
| 0.002 | 0.776 | 0.019 | Prostaglandin EP1 antagonist | 0.019 0.015 CID_20908 | CID_20908 | |
| 0.004 | 0.78 | 0.051 | Macrophage elastase inhibitor | 0.051 0.024 CID_20908 | CID_20908 | |
| 0.004 | 0.782 | 0.251 | HIV-1 integrase (3'-Processing) inhibitor | 0.251 0.006 CID_6195 0.06 0.047 CID_20908 | CID_6195 | |
| 0.008 | 0.786 | 0.219 | DNA polymerase beta inhibitor | 0.219 0.211 CID_6195 | CID_6195 | |
| 0.004 | 0.783 | 0.109 | Pim-1 kinase inhibitor | 0.109 0.05 CID_6195 | CID_6195 | |
| 0.004 | 0.788 | 0.065 | Selectin antagonist | 0.065 0.046 CID_20908 | CID_20908 | |
| 0.004 | 0.791 | 0.077 | Prostaglandin E2 antagonist | 0.077 0.02 CID_20908 | CID_20908 | |
| 0.005 | 0.8 | 0.254 | Alpha-glucosidase inhibitor | 0.254 0.185 CID_20908 | CID_20908 | |
| 0.006 | 0.801 | 0.132 | Topoisomerase II inhibitor | 0.132 0.059 CID_20908 | CID_20908 | |
| 0.013 | 0.827 | 0.203 | Platelet adhesion inhibitor | 0.203 0.069 CID_20908 | CID_20908 | |
| 0.004 | 0.819 | 0.102 | Protein-tyrosine phosphatase 1B inhibitor | 0.102 0.076 CID_20908 | CID_20908 | |
| 0.045 | 0.862 | 0.422 | Interleukin 2 agonist | 0.422 0.022 CID_20908 | CID_20908 | |
| 0.007 | 0.824 | 0.134 | Histone deacetylase class III inhibitor | 0.134 0.058 CID_20908 | CID_20908 | |
| 0.005 | 0.845 | 0.171 | Protein-tyrosine phosphatase inhibitor | 0.171 0.061 CID_20908 | CID_20908 | |
| 0.004 | 0.85 | 0.242 | HIV-1 integrase (Strand Transfer) inhibitor | 0.242 0.007 CID_6195 | CID_6195 | |
| 0.01 | 0.859 | 0.157 | Thioredoxin inhibitor | 0.157 0.015 CID_6195 0.103 0.045 CID_20908 | CID_6195 | |
| 0.003 | 0.855 | 0.03 | Prostacyclin antagonist | 0.03 0.025 CID_20908 | CID_20908 | |
| 0.007 | 0.871 | 0.12 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.12 0.025 CID_6195 | CID_6195 | |
| 0.004 | 0.873 | 0.382 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.382 0.028 CID_6195 | CID_6195 | |
| 0.004 | 0.874 | 0.347 | Dyrk kinase inhibitor | 0.347 0.038 CID_6195 | CID_6195 | |
| 0.003 | 0.877 | 0.076 | DNA-dependent protein kinase inhibitor | 0.076 0.01 CID_6195 | CID_6195 | |
| 0.002 | 0.88 | 0.039 | Kainate receptor 4 antagonist | 0.039 0.01 CID_6195 | CID_6195 | |
| 0.002 | 0.892 | 0.026 | Kainate receptor 5 antagonist | 0.026 0.011 CID_6195 | CID_6195 | |
| 0.005 | 0.901 | 0.113 | Cyclooxygenase inhibitor | 0.113 0.107 CID_20908 | CID_20908 | |
| 0.005 | 0.91 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.138 0.132 CID_6195 | CID_6195 | |
| 0.012 | 0.92 | 0.179 | MAP3K9 inhibitor | 0.179 0.027 CID_20908 | CID_20908 | |
| 0.004 | 0.913 | 0.11 | Phosphodiesterase 3A inhibitor | 0.11 0.026 CID_20908 | CID_20908 | |
| 0.004 | 0.916 | 0.089 | HIV-1 reverse transcriptase inhibitor | 0.089 0.036 CID_6195 | CID_6195 | |
| 0.005 | 0.924 | 0.488 | Cyclophilin D inhibitor | 0.488 0.054 CID_20908 | CID_20908 | |
| 0.004 | 0.929 | 0.136 | Cyclooxygenase 1 inhibitor | 0.136 0.066 CID_20908 | CID_20908 | |
| 0.005 | 0.935 | 0.027 | Granulocyte colony stimulating factor receptor agonist | 0.027 0.004 CID_6195 | CID_6195 | |
| 0.004 | 0.942 | 0.165 | Mcl-1 antagonist | 0.165 0.077 CID_6195 0.123 0.121 CID_20908 | CID_6195 | |
| 0.003 | 0.943 | 0.05 | Phosphodiesterase 3B inhibitor | 0.05 0.025 CID_20908 | CID_20908 | |
| 0.005 | 0.957 | 0.328 | Hypoglycemic | 0.328 0.043 CID_20908 | CID_20908 | |
| 0.004 | 0.958 | 0.198 | Bronchodilator | 0.198 0.018 CID_20908 | CID_20908 | |
| 0.008 | 0.991 | 0.086 | Interleukin 12 antagonist | 0.086 0.082 CID_20908 | CID_20908 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |